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Väestön keskimääräisen eliniän kasvaessa vanhenemiseen liittyvät silmän sairaudet, ku-
ten silmänpohjan ikärappeuma (age-related macular degeneration, AMD), muodostavat
vakavan ongelman.  AMD:n patogeneesin aikana verkkokalvon takana sijaitsevan veri-
verkkokalvoesteen (blood-retinal barrier, BRB) rakenne ja toiminta muuttuvat. BRB:llä
on monia tärkeitä tehtäviä normaalin näkökyvyn ylläpitämisessä, ja se koostuu kolmesta
osasta:  verkkokalvon pigmenttiepiteelistä (retinal pigment epithelium, RPE),  Bruchin
kalvosta ja suonikalvon kapillaarien endoteelistä. Matemaattinen mallintaminen tarjoaa
yksinkertaisen työkalun BRB:n ominaisuuksien tutkimiseen ja täten uusien hoitokeino-
jen kehittämiseen AMD:lle. Kokeellisessa tutkimuksessa  hyödynnetään usein niin sa-
nottuja  diffuusiokammioita BRB:n esteominaisuuksiin tutkimiseen. Tässä työssä luo-
daan  kaksi  mallia:  1) passiivinen  diffuusiomalli  BRB:n läpäisevyydestä  perustuen
BRB:n  ja  diffundoituvan  molekyylin  fysikaaliskemiallisiin  ominaisuuksiin  (BRB-
malli), ja 2) malli minityarisoidusta puoliperfuusiokammio ja tiettyjen parameterien vai-
kutuksesta sen toimintaan (kammiomalli).
BRB-malli  rakennettiin  yhdistämällä  fysikaalisia  teorioita  kirjallisuudesta  kuvaa-
maan diffuusion hidastumista eri tyyppisissä ympäristöissä.  Päätavoitteina oli rakentaa
malli ja validoida se kokeellisten tulosten perusteella, sekä tutkia BRB:n ja BRB:n osien
esteominaisuuksien  käyttäytymistä  suhteessa  diffundoituvan  molekyylin  ominaisuuk-
siin.  Kammiomalli on elementtimenetelmämalli, ja se raken nettiin käyttämällä COM-
SOL Multiphysics mallinnusohjelmaa. Mallin tarkoituksena on tutkia systeemin mitto-
jen ja muiden parametrien vaikutusta kammion toimintaan.
BRB-mallin tulokset osoittavat, että malli ennustaa oikein BRB:n läpäisevyyden ko-
koluokan, mutta ei kykene kuvaamaan tarkemmin molekyyliominaisuuksista, kuten li-
pofiilisyydestä ja koosta, johtuvaa käyttäytymistä. RPE muodostaa suurimman esteen
BRB:ssä, mutta Bruchin kalvo vaikuttaa hyvin lipofiilisiin molekyyleihin. Kammiomal-
lin tulokset näyttävät, että tämän tyyppisen kammion tarkkuutta rajoittaa molekyylin va-
paa  diffuusionopeus.  Kammion mittojen  ja  muiden  parametrien  diffuusionopeudesta
riippumaton vaikutus on pieni.
BRB-malli on ensimmäinen tyyppiään BRB:lle. Mallissa on ongelmia, mutta pienil-
lä parannuksilla sitä voidaan hyödyntää BRB:n esteominaisuuksien tutkimisessa. Tule-
vaisuudessa mallia voidaan viedä moneen suuntaan, kuten dynaamiseen säätelyyn  tai
tautimallinnukseen. Kammiomalli osoittaa tämän tyyppisen kammion ongelman: diffuu-
sionopeuden, joka yhdessä suurien diffuusiomatkojen kanssa tuottaa suuren mittausvir-
heen. Diffuusiokammioiden yleinen kyky mitata minkä tahansa epiteelin läpäisevyyttä
tulisi ottaa huomioon mittauksia tehdessä.
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Retinal diseases,  especially age-related macular degeneration (AMD),  are becoming a
large issue as life expectancy increases. Blood-retinal barrier (BRB) is located adjacent
to the retina and has many important functions in normal vision and it is the main site
associated with AMD pathogenesis. BRB consists of retinal pigment epithelium (RPE),
Bruch's  membrane  (BrM)  and  choriocapillaris  endothelium. Mathematical  modeling
provides a tool to study the properties of the BRB and thus new treatment options for
AMD. In experimental research, the BRB barrier function is usually measured with a
so-called diffusion chamber. In this thesis, two models are constructed: 1) a passive dif-
fusion model  across  the  BRB based on the physicochemical  properties  of  the BRB
(BRB model) and 2) a model of a miniaturized half-perfusion chamber concept to study
the effects of different parameters to the functionality of the system (chamber model).
The predictive BRB model was constructed by combining physical theories from the
literature to describe the hindered diffusion within a certain type of geometry. The main
objectives were to construct the model, to study the behavior of the permeability of the
whole BRB and its parts as a function of different molecular properties as well as to val-
idate the model by using experimentally measured permeabilities. The chamber model
was done by using finite element method (FEM) and by utilizing Comsol Multiphysics
FEM modeling software. The main interest was on the effects of certain system dimen-
sions and other chamber parameters to the error caused by the measurement system.
The results of the BRB model indicate that it predicts the correct magnitudes of the
BRB permeabilities, but fails to predict the more accurate behavior based on the molec-
ular properties of the diffusing molecule, such as molecular size and lipophilicity. As as-
sumed, the model confirms that RPE forms the most significant barrier in the BRB, as
the BrM has affects only the very lipophilic molecules. With the chamber model, the re-
sults show that the functionality of this kind of half-perfusion chamber is limited by the
free diffusion rate. The chamber dimensions and other parameters are less significant, as
they mainly just change the diffusion distances.
The proposed BRB model is the first model of this kind for the BRB. It can be uti-
lized to study the barrier properties in normal function and in disease,  especially with
little refinements. There are several directions towards which the model can be taken in
the future, such as dynamic regulation of the permeability. The chamber model clearly
suggests  that  the free diffusion rate  is the  main issue  with this kind of half-perfusion
chamber. The ability of the diffusion chambers to measure the actual absolute values of
permeability, and to provide reliable results, should be viewed with caution.
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NOTATION, ABBREVIATIONS AND TERMS
Aprobe Probe area (m2)
ABRB BRB area (m2)
c Concentration (mol)
cac Acceptor chamber concentration (µl ml−1)
cdc Donor chamber concentration (µl ml−1)
D Diffusion coefficient (m2 s−1)
D0 Free diffusion coefficient (m2 s−1)
DB Diffusion coefficient within a barrier (m2 s−1)
DB,eff Effective diffusion coefficient within a barrier (m2 s−1)
DBRBpc BRB-channel distance (m)
Dc Diffusion coefficient in the chamber model (m2 s−1)
DCF,ICL Diffusion coefficient within collagen fibril matrix in ICL
(m2 s−1)
DCF,OCL Diffusion coefficient within collagen fibril matrix in OCL
(m2 s−1)
DCF,ICL,eff Effective diffusion coefficient within collagen fibril matrix
in ICL (m2 s−1)
DCF,OCL,eff Effective diffusion coefficient within collagen fibril matrix
in OCL (m2 s−1)
Dcyt Cytoplasmic diffusion coefficient (m2 s−1)
Dcyt,eff Effective cytoplasmic diffusion coefficient (m2 s−1)
ddcBRB Chamber-BRB distance (m)
dICL OCL thickness (m)
Dm Diffusion coefficient within the matrix m (m2 s−1)
Dm,eff Effective diffusion coefficient within the matrix m (m2 s−1)
dm Fiber matrix thickness (m)
dOCL OCL thickness (m)
DPG,ICL Diffusion  coefficient  within  proteoglycan  matrix  in  ICL
(m2 s−1)
DPG,OCL Diffusion coefficient within proteoglycan matrix in OCL
(m2 s−1)
DPG,ICL,eff Effective diffusion coefficient within proteoglycan matrix
in ICL (m2 s−1)
DPG,OCL,eff Effective diffusion coefficient within proteoglycan matrix
in OCL (m2 s−1)
dRPE RPE cell flat-to-flat diameter (m)
dTJp TJ pore separation (m)
dTJss TJ strand separation (m)
F Faraday constant (9.65×104 C mol−1)
vii
ΔG Change in free energy
ΔGf Change in free energy of the fiber
ΔGs Change in free energy of the solute particle
ΔGsf Change in free energy between the solute particle and fiber
f Adjusted fiber volume fraction
Hm Hydrodynamic interactions in matrix m
h Separation distance between the fiber and particle (m)
hfen Fenestration height (m)
hLS Lateral space height (m)
Hp(λp) Pore hindrance factor
hpc Perfusion channel height (m)
hRPE RPE cell height (m)
Hs(λs) Slit hindrance factor
hTJ TJ region height (m)
hTJs TJ strand height (m)
I Unit matrix
J Diffusional flux (mol m−2 s−1)
kB Boltzmann's constant (1.38×10−23 J K−1)
Ka Association  constant  of  the  melanin  binging  reaction
(µM−1)
KD Octanol-water distribution coefficient
KP Octanol-water partition coefficient
lB Barrier thickness (m)
lcb Cell boundary length per unit area (m m-2)
lp Pore length (m)
ls Slit length (m)
M Cumulative amount of substance (mol)
mfr Perfusion flow rate (µl min-1)
Ms Solute's molecular mass (Da)
mV Membrane volume selectivity (mol cm-3)
nTJs TJ strand number
P Permeability coefficient (m s−1)
p Pressure (Pa)
PBRB BRB permeability coefficient (m s−1)
PBRB,c BRB  permeability  coefficient  in  the  chamber  model
(m s−1)
PBrM BrM permeability coefficient (m s−1)
PCE CE permeability coefficient (m s−1)
Pcyt Cytoplasm permeability coefficient (m s−1)
Pfen Fenestration permeability coefficient (m s−1)
PICL ICL permeability coefficient (m s−1)
viii
PLS Lateral space permeability coefficient (m s−1)
Pmem Membrane permeability coefficient (m s−1)
POCL OCL permeability coefficient (m s−1)
Ppara Paracellular permeability coefficient (m s−1)
PRPE RPE permeability coefficient (m s−1)
PTJ TJ permeability coefficient (m s−1)
Ptrans Transcellular permeability coefficient (m s−1)
P*BRB,c Simulated permeability coefficient based on the flux over
BRB (m s−1)
P*out,c Simulated  permeability  coefficient  based  on  the  flux
through the outlet (m s−1)
qA,f Fiber's surface charge density (C m−2)
qA,PG Proteoglycan surface charge density (C m−2)
qA,s Particle's surface charge density (C m−2)
qs Solute molecule's charge
R Universal gas constant (8.31 J mol−1 K−1)
rCF Collagen fibril radius (m)
rdia Diaphragm pore radius (m)
rf Fiber radius (m)
rp Pore radius (m)
rPG Proteoglycan radius (m)
rs Solute particle radius (m)
rSE Stokes-Einstein radius (m)
rSu Sutherland radius (m)
rTJp TJ pore radius (m)
Sm Steric interactions in matrix m
T Absolute temperature (K)
t Time (s)
u Velocity field (m s−1)
V Van der Waals volume (cm3 mol−1)
WLS Lateral space half-width (m)
Ws Slit half-width (m)
WTJ TJ region half-width (m)
β Dimensionless fiber radius
ϵ Absolute permittivity (F m−1)
ϵ0 Permittivity of vacuum (8.85×10−12 F m−1)
ϵdia Relative surface area of the diaphragm pores
ϵLS Relative surface area of the lateral space
ϵopen TJ open part size
ϵp Relative surface area of the pores
ϵr Relative permittivity
ϵs Relative surface area of the slit
ix
ϵTJo Relative surface area of the open TJ part
ϵTJp Relative surface area of the TJ pores
ϵTJss Relative surface area of the space between the strands
η Dynamic viscosity (Pa s)
κD Reciprocal of Debye screening length (m-1) 
ζ Viscous frictional coefficient (N s m-1)
µ Dimensionless separation distance
Φm Partition coefficient between the matrix m and solvent
Φm,e Partition coefficient between the matrix m and solvent in-
cluding the electrostatic interactions
φCF,ICL Collagen fibril volume fraction in ICL
φCF,OCL Collagen fibril volume fraction in OCL
φf Fiber volume fraction
φPG,ICL Proteoglycan volume fraction in ICL
φPG,OCL Proteoglycan volume fraction in OCL
ρ Fluid density (kg m−3)
σf Dimensionless fiber's surface charge density
σs Dimensionless particle's surface charge density
τ Dimensionless particle radius
τLS Lateral space tortuosity
Da Dalton,  a unit  used to indicate molecular mass (1 Da =
1.66×10−23 kg)
Å Ångstrom, a unit used to indicate molecular sizes (1 Å =
1×10−10 m)
AMD Age-related macular degeneration
BAB Blood-aqueous barrier
BBB Blood-brain barrier
BC Boundary condition
BRB Blood-retinal barrier/outer blood-retinal barrier
BrM Bruch's membrane
Ch-BRB Choroid and blood-retinal barrier
Ch-BrM Choroid and Bruch's membrane
CE Choriocapillaris endothelium
CE-BL Basal lamina of the choriocapillaris endothelium
CNV Choroidal neovascularization
ECM Extracellular matrix
EL Elastic layer
FITC Fluorescein isothiocyanate
GAG Glycosaminoglycan
iBRB Inner blood-retinal barrier
xICL Inner collagenous layer
OCL Outer collagenous layer
PEDF Pigment epithelium-derived growth factor
PEG Polyethylene glycol
POS Photoreceptor outer segment
RPE Retinal pigment epithelium
RPE-BL Basal lamina of the retinal pigment epithelium
TER Transepithelial/endothelial electric resistance
TJ Tight junction
VEGF Vascular endothelial growth factor
Diaphragm A fiber structure covering the fenestrations
Fenestration A pore through an endothelium
Hydrodynamic interactions Mechanical interactions mediated by liquid
Lipophilicity Ability of chemical compound to dissolve in fats
Melanin Pigment found e.g. in the RPE
Paracellular Space between the cells
Steric interactions Mechanical interactions caused by the obstacles
Transcellular Transport pathway through the cells
11 INTRODUCTION
In this thesis, two mathematical models are constructed to  predict the permeability of
the blood-retinal barrier  (BRB)  and the functionality of a permeability measurement
system. BRB is a layer in the eye, located just behind the retina,  which has important
roles in normal retinal function. In addition, it is the primary location for many retinal
diseases, most notably age-related macular degeneration (AMD). This disease causes
impairment of vision or even blindness, and thus forms a risk for the aging population
due to increasing life expectancy. AMD is the third most common cause of blindness in
the world after cataract and glaucoma (Pascolini & Mariotti 2012), and the most com-
mon cause of adult blindness in developed countries (Augood et al. 2006). It has been
estimated that in the United States 1.75 million people and more than 10 % of the peo-
ple older than 80 years have AMD (Friedman et al. 2004). The percentages are similar
in Europe (Augood et al. 2006).
During AMD pathogenesis, many of the BRB functions are impaired, among them
the barrier function, due to the compositional changes in the BRB. To enable the devel-
opment of novel treatments for AMD, it is important to be able to study the BRB in nor-
mal function and in disease. Mathematical models present one useful method for study-
ing this barrier function without the need for any cells or tissues. Currently, the mathe-
matical modeling of the BRB is in its infancy. Models that include the BRB are gener-
ally pharmacokinetic models (Mac Gabhann et al. 2007; Amrite et al. 2008; Ranta et al.
2010) and represent the BRB only with one simple constant permeability value. There
are some more accurate models of other barrier structures, such as the cornea (Edwards
& Prausnitz 1998; 2001) and skin (Mitragotri 2003). In addition to mathematical mod-
els, so-called biological in vitro models can be constructed to further decrease the need
for animal tissues. To be able to study the properties of in vitro models, proper tools are
needed. Traditionally, diffusion chambers are used to study the molecular permeability
across the BRB (Hussain et al. 2002; Pitkänen et al. 2005; Steuer et al. 2005; Cheruvu
& Kompella 2006; Kadam et al. 2011). However, these devices have certain problems,
such as large tissue areas and volumes, which require large amount of cells and expen-
sive drugs. One option to overcome these problems is to miniaturize the chamber.
The main aim of this thesis is to create models, that predict the BRB permeability
and describe the functionality of one type of diffusion chamber. To meet this aim, two
computational models are constructed 1) a model of passive diffusion across the BRB
based on the physiocochemical properties of the BRB and diffusing molecule  (BRB
model), and 2) a model of a conceptual half-perfusion chamber for the BRB permeabil-
ity studies (chamber model). The objectives of the first model (BRB model) are to con-
struct and validate the model as well as to use it to determine the importance of different
2parts of the BRB as barriers. The objectives of the second model (chamber model) are to
predict the importance of certain dimensions and other parameters for the functionality
of  the  chamber.  The chamber  model  was  constructed  using  COMSOL Multiphysics
FEM software (v4.3)  and all  the  calculation  for  both models were  carried  out with
Mathworks MATLAB (R2012a). These models are part of an ongoing research on BRB
conducted by Tampere University of Technology and University of Tampere. 
The structure of the thesis is as follows. First, the basic background theory of the
anatomy and physiology of the eye and BRB, aging of the BRB and AMD pathology as
well as general epithelial transport  concepts are introduced. These are followed by the
description of the physics of diffusion and permeability. In addition, the general princi-
ples of modeling  physiological systems are discussed. Then, the two models are pre-
sented, followed by results and discussion.
32 THEORETICAL BACKGROUND
This chapter describes the basic theoretical background of biology, physics and model-
ing concerning this thesis. First, the basic anatomy of the eye and the blood-ocular bar-
riers is introduced, followed by the anatomy and physiology of the BRB and its compo-
nents. Then, the BRB aging process and related AMD pathology are described. The next
section will go through the epithelial transport mechanisms and methods of studying the
BRB permeability. This is followed by the introduction of basic physics concerning dif-
fusion. Finally, the concepts of a model and mathematical modeling are explained, fol-
lowed by the description of the current state of BRB modeling.
2.1 Anatomy of the eye and blood-ocular barriers
As the organ responsible for one of the most important senses, the eye has a highly
complex function  and  structure.  As light  comes into  the  eye,  it  passes  through the
cornea, after which the lens focuses it to the retina at the back of the eye. The retina has
two types of photoreceptor cells – cones and rods – which are located in the outermost
part of the retina, away from the incoming light. Cones mediate the color vision and
work better in bright light conditions. In humans, they are mostly concentrated around
the central part of the retina where the light is focused by the lens. This region is highly
pigmented and is known as the macula and it is responsible for the sharp vision. Rods
function in less intense lighting and can not distinguish colors. They are more numerous
in the peripheral regions of the retina. Photoreceptors form the input of the retina and
the  output  is  formed  by  retinal  ganglion  cells.  Between  the  two,  specialized  cells
process the signal. The axons of ganglion cells form the optic nerve, which leaves the
eye through the optic disc and transmits the signal to the brain. (Marieb 2009.)
Ocular blood supply is provided by the vascular layer located just outside the retina.
In the anterior parts of the eye, the vascular layer is known as the ciliary body and in the
posterior parts the choroid. Between the choroid and the retina, there is an important cell
monolayer called retinal pigment epithelium (RPE). The outermost protective layer of
the eye consists of two parts: the anterior cornea and posterior sclera. Inside of the eye
is filled with fluid, which is divided into two segments by the lens. The anterior segment
is known as the aqueous chamber and it is filled with clear water-like fluid. The poste-
rior  segment  is  called  the  vitreous  and it  contains  gel-like  vitreous  humor.  (Marieb
2009.) The gross anatomy of the eye is presented in Figure 2.1A.
It is important to maintain the right physicochemical environment inside the eye to
enable the normal operation of the retinal cells. The structures mainly responsible for
this function are called blood-ocular barriers. The two main barriers are categorized ac-
4cording to  their  location:  the  blood-retinal  barrier  (BRB) and blood-aqueous  barrier
(BAB). (Cunha-Vaz 1997.) They are  both considered  being part of the more studied
blood-brain barrier (BBB), which is formed by the endothelial cells of the brain capillar-
ies and which maintains the homeostasis inside the central nervous system (Rizzolo et
al.  2011).  The constant  chemical  and osmotic  changes in  systemic blood circulation
mean that the BRB and BAB must restrict the movement of fluid and molecules be-
tween the vasculature and the eye. One important aspect of this function is the outwards
transport of the waste products from the metabolically active tissues. (Cunha-Vaz 1997.)
In some mammals, such as humans and pigs, the retinal blood supply comes from
two sources. The inner part of the retina is supplied by the retinal capillaries and the
outer part by the choriocapillaris network. (Steuer et al. 2005.) The BRB is thus divided
into two parts: the inner BRB (iBRB) and outer BRB, of which the latter is discussed in
the next section. iBRB is formed by the endothelial cells of the retinal capillaries and
the tight junctions (TJs) between them. The endothelial cells reside on a basal lamina
and are covered by the processes of astrocytes and Müller cells, which regulate the
tightness  of  the iBRB  according  to  the  changes  in  the  retinal  microenvironment.
(Cunha-Vaz 2009.) BBB and iBRB are structurally very similar: they are both orders of
magnitude tighter than the capillaries in systemic circulation and they have no fenestra-
tions. Some species, e.g. horses and rabbits, lack the retinal capillaries and thus they
also lack the iBRB. (Steuer et al. 2005.) Figure 2.1B presents the locations of the retinal
capillaries in the retina.
BAB comprises the iris blood vessel endothelium and the ciliary epithelium. These
barriers are  more permeable than  the BRBs, as they allow a small  concentration of
plasma proteins to diffuse into the aqueous humor. There are no diffusion barriers be-
Figure 2.1. A: The gross anatomy of the human eye. Redrawn from Marieb (2009) B: A
more detailed anatomy of the locations of the retinal capillaries, RPE, Bruch's mem-
brane and choriocapillaris in relation to the retina. Note that the dimensions are not
correct. (POS: photoreceptor outer segments; RPE: retinal pigment epithelium)
5tween the aqueous and vitreous humor or the vitreous humor and the retina. Hence the
BAB is  an  important  component  in  the  regulation  of  the  retinal  microenvironment.
(Cunha-Vaz 1997.)
2.2 Outer blood-retinal barrier (BRB)
The blood supply to the outer part of the retina – including the metabolically highly ac-
tive photoreceptors – comes from the choriocapillaris network. The barrier between the
choriocapillaris and other retina is formed by the outer blood-retinal barrier, which from
now on will be referred to as the BRB. This barrier ensures the correct physicochemical
conditions in the outer retina and especially around the photoreceptors. BRB includes
three layers: the choriocapillaris endothelium (CE), Bruch's membrane (BrM) and reti-
nal pigment epithelium (RPE). The tightness of the BRB is mainly due to the RPE and
its TJs. BRB is structurally analogous to the ventricular part of the BBB: the main bar-
rier is formed by the epithelium, not the endothelium. (Rizzolo et al. 2011.) BRB is ex-
tremely important to the retinal well-being, and in species without retinal capillaries,
this tissue is alone responsible for the maintenance of the whole retina. The location of
the RPE, BrM and choriocapillaris in relation to retina is presented in Figure 2.1B and
Figure 2.2 shows the BRB in more detail.
2.2.1 Retinal pigment epithelium (RPE)
RPE is a monolayer of polarized and pigmented RPE cells that are connected to each
other by tight junctions (TJs). The TJs form an important part of the barrier function of
the whole BRB. (Rizzolo et al. 2011.) RPE is located between the photoreceptor cells of
the retina and the choroid. The cells are anchored to BrM on their basal side and are in
close contact with the photoreceptor outer segments (POS) on the apical side. At the pe-
ripheral  regions  of  the  retina,  RPE continues  as  the  membrane of  the  ciliary body.
(Bhutto & Lutty 2012.) Among all epithelial tissues, RPE is a rare epithelium since the
apical side does not face a lumen, but a solid tissue. (Rizzolo et al. 2011.)
Characteristics of the RPE cells
RPE cells are hexagonal in shape and in humans they have an average height and diam-
eter of 8 and 16 µm, respectively (Garron 1963). In the macular region, the cells are
slimmer and higher with the height and diameter of 11–14 and 10–14 µm, respectively
(Garron 1963; Boulton & Dayhaw-Barker 2001). In the peripheral regions, the cells are
more irregularly shaped, flatter and the diameter can be as large as 60 µm (Boulton &
Dayhaw-Barker 2001).
The apical surface of the RPE cells has two types of microvilli: long and thin ones
with the length of 5–7 µm, and shorter ones that are more specifically shaped and form
a sheath around the POS's. (Boulton & Dayhaw-Barker 2001.) The basal surface of the
cells has infoldings that extend up to 1 µm into the cell cytoplasm. Both the microvilli
6and infoldings  increase  the  respective  surface  areas  and thus  facilitate  the  transport
properties of the cells. (Garron 1963.)
The nucleus and most of the usual organelles, such as the abundant mitochondria,
reside near the basal surface of the RPE cells. The melanin pigment is packed into gran-
ules, known as melanosomes. They are located near the apical surface and sometimes
inside the microvilli. (Garron 1963.)
Functions of the RPE
RPE has multiple roles.  In addition to being a barrier, it  functions as a bidirectional
transporter. The polarization of different membrane transport proteins is essential for
this  role.  Important  actively transported  molecules  from retina  to  blood  vessels are
metabolic end products of the photoreceptors, such as lactic acid. The transport of glu-
cose and retinol (vitamin A) from blood to retina is essential for the visual function.
Ions – such as Cl−, K+, Na+ and HCO3− – are transported to form electrochemical gradi-
ents, which are then used to drive the passive fluid transport outwards from the retina
together with the  molecular transport. The  RPE ion-transport also creates a buffer for
the subretinal space between  the RPE and photoreceptors to compensate for the fast
changes in the ion composition due to retinal signaling. (Strauss 2005.)
Figure  2.2. The main components of BRB: Retinal pigment epithelium, Bruch's mem-
brane and choriocapillaris. (POS: photoreceptor outer segments; TJs: tight junctions;
RPE-BL: basal lamina of RPE; ICL: inner collagenous layer; EL: elastic layer; OCL:
outer collagenous layer; CE-BL: basal lamina of choriocapillaris endothelium; CE:
choriocapillaris endothelium) 
7In addition to the transport properties, RPE has an essential role in the photoreceptor
visual cycle. In photoreceptors, the light sensitive molecule is the chromophore 11-cis
retinal. The conformation of 11-cis retinal changes to all-trans retinal  due to light ab-
sorption. This chromophore in all-trans conformation is reduced to all-trans retinol and
transported  into  the RPE cells, which have the enzymes to isomerize it to the active
form, thus enabling the recycling of the chromophore. Retinal is also isomerized from
retinol transported from blood circulation. (Strauss 2005.)
POS's consist of discs which are packed of visual pigment. These discs and the tips
of the POS's need to be renewed constantly as they are damaged from concentrated light
energy. One major role of the RPE cells is to phagocytose and degrade the shed POS
segments. (Strauss 2005.) One RPE cell interacts with 20–30 POS's (Bhutto & Lutty
2012) as well as phagocytoses and degrades 300 million discs during  its 70-year life-
span (Marshall 1987). The concentrated light energy and oxygen-rich environment, cou-
pled with the reactive oxygen species produced by the degradation of the POS discs,
create hazardous conditions for the proteins, lipids and DNA in the RPE cells. They pro-
tect themselves by three mechanisms: the light absorbing melanosomes,  antioxidants
and ability to repair damaged biomolecules. (Strauss 2005.)
RPE cells also produce many growth factors, e.g. vascular endothelial growth factor
(VEGF) and pigment epithelium-derived growth factor  (PEDF). These growth factors
are not only important for the well-being and correct function of the photoreceptors, but
also for the choriocapillaris. (Strauss 2005.)
2.2.2 Tight junctions of the RPE
Tight junctions (TJs) are essential for the barrier function of the RPE, as they seal the
space between the RPE cells and thus retard the paracellular diffusion of molecules.
(Rizzolo et al. 2011.) Paracellular refers to movement between the cells, as opposed to
transcellular which refers to movement through them. TJs, also known as zonula occlu-
dens, are cell-cell adhesions that encircle the apical end of the lateral surface of epithe-
lial cells. They connect the cell membranes of adjacent epithelial cells together, thus
sealing the lateral space. (Alberts et al. 2008.)
Structure of the TJs
TJs are made out of a continuous belt of parallel strands that create a seal around the
cells. The TJ strand structure is schematically presented in Figure 2.3. When viewed at
the plane of the membrane, the branching strands form a web-like pattern. The number
of  the  parallel  strands  and  complexity  of  this  network  differs  between  epithelia.
(Schneeberger & Lynch 2003.) For example, the mean number of parallel strands in the
RPE of a late chicken embryo was measured to be five (Rahner et al. 2004).
TJs consist of three classes of proteins: transmembrane proteins which form the seal,
adapter proteins which help to form the structure, and effector proteins which regulate
the TJs. The main transmembrane protein families are claudins and occludins. The bar-
8rier function is mainly created by claudins, as the presence of occludins is not necessary.
(Schneeberger & Lynch 2003.) The TJ strands are formed by rows of so-called 10-nm
particles consisting of claudins, seen in Figure 2.3C. Small pores shown in Figure 2.3D
are formed in this particle structure, enabling the movement of ions and small mole-
cules. These pores are ion and charge selective, a property which arises from the extra-
cellular loops of the claudins. There are 24 members identified in the claudin family,
and they have different selectivities. In addition to the selectivity, some claudins make
the TJs leakier than others. (Anderson & Van Itallie 2009.) Claudin-19 is the prominent
claudin in the human RPE TJs (Peng et al. 2011).
Functions and characteristics of the TJs in the RPE
As a part of the intercellular junctional complex, the TJs' main function is the regulation
of the diffusion from one side of the cells to the other. This way they separate the two
compartments.  One important function is the creation of the apical-basolateral mem-
brane  polarity  by  restricting  the  lateral  diffusion  of  membrane  proteins  and  lipids.
(Schneeberger & Lynch 2003.) In addition to TJs, the RPE intercellular junctional com-
plex includes adherens  junctions,  that  provide a mechanical  connection between the
cells, and gap junctions, that connect the cytoplasms of adjacent cells (Hudspeth & Yee
1973).
Despite their name, TJs can be tighter or leakier depending on the tissue. Epithelial
or endothelial tightness is usually described by transepithelial or transendothelial electri-
cal resistance (TER). TER describes how much the cell layer resists the movement of
ions from one side to the other. As ions diffuse mainly through the paracellular pathway,
TJs form the major component in TER. However, also the transcellular pathway through
ion channels has an impact. (Krug et al. 2009.) The TER value of  the RPE is around
135–600 Ω cm2, varying between species, and it is somewhere between leaky and tight
epithelia. The extreme ends of the scale are the leaky capillaries of the systemic circula-
tion and tight BBB with values between 5–10  Ω cm2 and 1000–2000  Ω cm2, respec-
Figure 2.3. The structure of the TJs. A: A cross section view of TJs between two cells.
B: TJs viewed at the plane of the membrane, showing the web-like structure and strand
breaks.  C:  Strands  are formed by  10-nm particles  (the  other  cell  membrane is  not
shown). D: There are small TJ pores between the 10-nm particles. A and B redrawn
from Rizzolo et al. (2011), C and D redrawn from Van Itallie & Anderson (2004).
9tively. (Rizzolo et al. 2011.) TER value does not measure tissue quality us such, as each
epithelium or endothelium has its own function with suitable TER value for it (Rizzolo
2007). The relationship between the number of parallel TJ strands and TER vary among
different  studies.  Claude  (1978)  found  a  logarithmic  correlation  between  them,  but
Stevenson et al. (1988) found over tenfold difference in TER with two cell lines with a
similar strand numbers.
Although they have differences in structure and TER values, the permeability of
drug molecules through the BBB and whole BRB is fairly similar, as shown by Steuer et
al. (2005) in an in vitro study. There are two diffusion pathways through the TJs. Small
molecules are able to diffuse through the small structural pores. The radius of these
pores was measured to be around 0.4 nm by Van Itallie et al. (2008) by using polyethyl-
ene glycol (PEG) oligomers with different molecular masses. In spite of the small radius
of the pores, also larger molecules are able to cross the TJs. This is due to the highly dy-
namic  TJ  structure:  the strands constantly break down and form new contacts. Larger
molecules are able to permeate through these temporary breaks. The existence of multi-
ple parallel strands forming the web-like structure restricts the diffusion through this
pathway, even if one of the strands breaks. (Sasaki et al. 2003.)
In conclusion, TER and molecular permeability of the TJs are independently regu-
lated and measure different TJ functions. Because of this, neither of them fully defines
the TJ tightness. (Rizzolo 2007.)
2.2.3 Bruch's membrane (BrM)
Located between the RPE and choriocapillaris network, BrM is an acellular extracellu-
lar matrix (ECM) layer with different roles in the retinal function and especially in ag-
ing and pathology (Booij et al. 2010). It consists of five layers and has a total thickness
of 2–4 µm (Bhutto & Lutty 2012). The composition and thickness of the tissue vary
across the retina. For example, the thickness of the whole BrM decreases (Garron 1963)
and the thickness of the central elastic layer increases in the peripheral regions of the
retina (Booij et al. 2010).
Layers of BrM
The five layers are from the innermost to the outermost: the basal lamina of the RPE, in-
ner collagenous layer, elastic layer, outer collagenous layer and basal lamina of the CE.
The characteristic anatomical features of these layers change with age and the dimen-
sions given in this section are determined from a young, healthy eye. (Booij et al. 2010).
The layers are schematically presented in Figure 2.2.
The basal lamina of the RPE (RPE-BL) is 0.14–0.15 µm in thickness. It consists of
type IV collagen, laminin, fibronectin, and heparan sulfate as well as chondroitin/der-
matan sulfate proteoglycans. The inner collagenous layer (ICL) has a thickness of ap-
proximately 1.4 µm and it is composed of collagen types I, III and V. (Booij et al. 2010.)
The collagen fibrils are tightly interwoven and randomly oriented in the plane of the
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layer  with  occasional  lengthwise  attachments  to  each  other  (Goldbaum &  Madden
1982). The fibrils have a diameter of 60 nm, and the space between them is filled with
ground substance consisting mainly of hyaluronic acid, chonroitin sulfate and dermatan
sulfate proteoglycans. The elastic layer (EL) is 0.8 µm thick and is formed by varying
sizes of elastic fibers consisting of elastin. The fibers form a perforated sheet with large
holes. In addition, EL contains other ECM components, such as type VI collagen and fi-
bronectin. The collagen fibrils of the collagenous layers frequently cross the EL. The
outer collagenous layer (OCL) is 0.7 µm thick and it is compositionally identical to the
ICL. (Booij et al. 2010.) However, the collagen fibrils are less tightly interwoven than in
the ICL (Goldbaum & Madden 1982). The OCL is also continuous with the ECM of the
choroid, thus forming the choroidal intercapillary pillars (Moore & Clover 2001). The
basal lamina of the CE (CE-BL) is approximately 0.14 µm thick and it is not a continu-
ous layer of  BrM, as it only covers the surfaces of the endothelial cells. It consists of
laminin, heparan sulfate proteoglycan and collagen types IV, V and VI. (Booij et al.
2010.)
In BrM, as well as in other tissues of the body, collagens are the most common fam-
ily of proteins in ECM. Collagens are found in different conformations. Of the types
found in the BrM, types I, III and V are fibrillar, type IV forms a sheet-like network, and
type VI has an important role in maintaining tissue integrity. (Hulmes 2008.) The fibril-
lar collagen molecules are made of three polypeptide chains wrapped helically around
each other. The collagen molecules in turn form larger units known as collagen fibrils,
which can have a diameter of 10–300 nm. Fibrils can further form aggregates known as
collagen fibers. Proteoglycans compose of glycosaminoglycan (GAG) chains covalently
linked to a core protein. GAGs, like chonroidin sulfate, dermatan sulfate and heparan
sulfate, are linear polysaccharide chains made out of repeating disaccharide units. One
of the sugars in the unit is an amino sugar, which is usually sulfated. Due to the sulfates
and carboxyl groups in the sugars, GAGs have a highly negative charge in the physio-
logical pH. The GAG chains occupy a high volume compared to their mass, and they
form gels that fill most of the extracellular space. (Alberts et al. 2008.)
Functions of BrM
BrM has three main functions: 1) to act as a passive diffusion barrier between the chori-
ocapillaris and RPE, 2) to form a platform for adhesion, migration as well as maybe for
the differentiation of the RPE cells, and 3) to form a barrier restricting the migration of
cells from one side to the other (Booij et al. 2010). The diffusion barrier properties of
BrM are considered the most important ones for this thesis.
The diffusion through BrM is highly affected by the molecular composition, which
changes with age (Hussain et al. 2010). Starita et al. (1997) found that the site of major
fluid flow resistance is the ICL. It is possible, that the ICL also forms the main resistive
layer against the diffusion of biomolecules. In the molecular scale the proteoglycans –
especially chondroitin and dermatan sulfate – form the most significant barrier  with
their negative surface charges. The negative charge causes proteoglycans to bind water,
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cations and positively charged molecules, and to repel negatively charged molecules.
(Booij et al. 2010.)
The relationship between the molecular size and BrM permeability is an inverse re-
lationship  with  small  molecules  permeating  orders  of  magnitude  faster  than  macro-
molecules (Hussain et al. 2010; Zayas-Santiago et al. 2011). The size exclusion limit of
BrM was found to be over 200 kDa in the young tissue and this limit decreases with
age. The limit is sufficient for the diffusion of retinol, which is transported in a complex
with a molecular mass of 75 kDa and which is essential to the visual cycle. (Moore &
Clover 2001.) In addition to the properties of the molecule and the matrix composition,
the BrM permeability depends on the surrounding hydrostatic and osmotic pressures
(Booij et al. 2010) and pH (Guymer et al. 1998).
2.2.4 Choriocapillaris endothelium (CE)
The choroidal blood comes from the ophthalmic artery, which branches into short poste-
rior and long anterior ciliary arteries. These arteries in turn branch into small arteries
and eventually terminate in the choriocapillaris. (Anand-Apte & Hollyfield 2011.) The
choriocapillaris network lies in a single plane under BrM and is arranged in a lobular
manner (Bhutto & Lutty 2012). The blood perfusion of the choriocapillaris is very high
in comparison with other tissues: 1400 ml min−1 100 g tissue−1 (Strauss 2005). The arte-
rioles and venules connect to this plane at right angles in the macular region and they lie
in the choriocapillaris plane in the peripheral region (Bhutto & Lutty 2012). The venous
collecting  vessels  exit  the  eye  through  the  vortex  veins  (Anand-Apte  & Hollyfield
2011).
The  choriocapillaris  have  large,  elliptical  lumen,  with  a  major  axis  diameter  of
nearly 20 µm in the macular region and 18–50 µm in the peripheral region (Anand-Apte
& Hollyfield 2011). The wall of the choriocapillaris composes of the endothelial cells
CE) and basal lamina. The nuclei and most of the cytoplasm of the CE cells are on the
choroidal side. (Bernstein & Hollenberg 1965.) The CE cells are fenestrated with circu-
lar openings across the cells connecting the choriocapillaris lumen to  the ECM of the
choroid. The fenestrations of the choriocapillaris have diaphragm spanning over them
(Anand-Apte & Hollyfield 2011). The fenestrations and a diaphragm are presented in
Figure  2.4. The diaphragm consists of radial fibrils, that interweave in the center and
particles that line the edges of the pore. This leaves triangular openings between the fib-
rils.  (Bearer & Orci 1985.) The diameter of choriocapillaris fenestrations is approxi-
mately 80 nm and the open space in the radial direction is approximately 12 nm. The
fenestrations are usually grouped together into clusters, where the cytoplasm is attenu-
ated. (Melamed et al. 1980.) The fenestrations are more prevalent in the retinal side.
Also the vascular endothelial growth factor (VEGF) receptors in the cell membrane are
expressed in the retinal side, indicating polarization towards the RPE. (Bhutto & Lutty
2012.)
Due to the fenestrations, the choriocapillaris are leaky, and the significance of para-
cellular and transcellular transport is small (Michel & Curry 1999). The fenestrations
12
readily enable the diffusion of small molecules, but Pino & Essner (1981) found that the
diffusion of macromolecules with a radius larger than 3.2 nm is greatly hindered in the
eye of a rat. However, the size of the retinol transportation complex has a radius of 3.7
nm, which means that there is some other means of transport, like transcellular vesicular
pathway (Pino & Essner 1981).
2.2.5 Regulation of the BRB permeability
The BRB permeability is mainly regulated by the RPE, as it is the tightest layer of the
BRB. Paracellular RPE permeability is regulated by the TJs and transcellular RPE per-
meability by the cell membrane transport proteins as well as by metabolic modification.
(Rizzolo 2007.)  The BrM regulation of permeability is based on passive mechanisms,
such as changes in composition (Booij et al. 2010), which are relatively slow compared
to the regulation done by the RPE.
The permeability and selectivity of  the TJs can be regulated physiologically and
pharmacologically. The photoreceptors are able to regulate the function and structure of
the RPE TJs due to the close interaction between the two tissues. In addition to the tis-
sue-tissue interactions between the RPE and the retina, the regulation is also mediated
by diffusible factors secreted by the retinal cells. (Peng et al. 2003.) The retina can regu-
late the RPE by affecting the protein synthesis, degradation and distribution to the apical
and basolateral membranes, as well as the barrier function of  the TJs. The factor se-
creted by retina affect the expression of claudin and occludin genes, thus affecting the
TJs. The half-lifes of the claudins and occludins are around 4–12 h and 1.5 h, respec-
tively. The short half-lifes, especially that of occludins, facilitate a fast regulation of the
TJ permeability and selectivity, and enable fast reaction to physicochemical changes.
(Rizzolo et al. 2011.)
The function of cell membrane carrier proteins can be regulated in different ways.
The regulation can happen at protein synthesis stage, as for example with glucose trans-
port proteins during the development. Different types of glucose transporters are ex-
pressed during different stages of development due to different needs.  The regulation
can happen by directly regulating the protein functions. For example, the transportation
Figure 2.4. Fenestrations of the choriocapillaris. A: A cross section view of the fenes-
trations between the lumen and OCL. B: A view on the plane of the endothelium of the
fenestrations. C: A more detailed view of a diaphragm, showing the radial fiber struc-
ture. Adapted from Bearer & Orci (1985). (OCL: outer collagenous layer)
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of some ions, like Na+, create electrochemical gradient that drive the transport proteins.
Thus, by controlling the movement of Na+, the active transcellular transport can be reg-
ulated. Also, as TJs affect the movement of ions, they affect this transport pathway.
(Rizzolo 2007.) The different methods of transcellular transport are discussed in detail
later.
2.3 Aging of BRB and ocular diseases
The boundary between a normal aging process and an eye disease is not always clear.
Therefore, main focus of this section is in the age-related changes occurring in the BRB
and in the effects of diseases on the BRB and its permeability. 
2.3.1 Aging of BRB
During the life-span of the BRB, there are dramatic changes in the structure and func-
tionality of the RPE, BrM and choriocapillaris. Many of these changes lead to impair-
ment in the functions of the whole BRB.
Changes in the RPE
The main changes in  the  RPE are more compositional and functional than structural.
The main morphological age-related changes in the RPE cells are a loss of cell shape,
hyperplasia,  atrophy  and  areas  of  hyper-  and  hypopigmentation.  (Boulton  &  Day-
haw-Barker 2001).
One of the main sources for the changes in the RPE is oxidative stress, caused for
example by the degradation of the POS's. The highly oxidative environment leads to ox-
idative modification of lipid-related molecules that are transported to choriocapillaris or
accumulate to form deposits in the BrM. (Booij et al. 2010.) The degradation process
also creates lipofuscin pigment, which accumulates in melanosomes forming melano-
lipofuscin granules. Melanosomes are degraded by fusion with lysosomes, resulting in a
decrease in the number of melanosomes.  The accumulation of lipofuscin and other cy-
totoxic molecules to cytoplasm continues with age and can eventually lead to adverse
effect, such as apoptosis. (Strauss 2005.)
Changes in BrM
The main changes in  the BRB permeability during aging result  from changes in BrM.
The structural changes in  the  BrM encompass changes in molecular composition and
thickening. The main compositional changes are the increase in collagen cross-linking,
changes in proteoglycan synthesis, formation of mineral deposits, accumulation of ad-
vanced glycation end-products,  lipids and oxidized metabolic  end-products from  the
RPE as well as formation of drusens (Booij et al. 2010). Drusens are extracellular de-
posits that form between the RPE and BrM and contain incompletely digested material
from the RPE, like lipids and oxidized end-products of the POS degradation. They tend
to form on top of the intercapillary pillars, where there  is no blood flow underneath.
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(Bhutto & Lutty 2012.) The thickness of the RPE increases by 135 % in normal lifespan
due to the compositional changes, mainly in the ICL (Ramrattan et al. 1994).
These structural changes lead to functional changes resulting for example in loss of
elasticity (Booij et al. 2010), decrease in hydraulic conductivity (Moore et al. 1995) and
decrease in molecular permeability (Hussain et al. 2002; Hussain et al. 2010). The main
structural changes that influence the molecular permeability are the increased collagen
cross-linking and solubility, accumulation of lipids and the formation of drusens. The
collagen cross-linking increases the density of the collagen network, thus decreasing the
permeability. The lipids accumulate  into ICL and EL and form a so-called lipid wall,
which affects especially the permeability of hydrophilic molecules. (Booij et a. 2010.)
The changes in proteoglycan synthesis, meaning that the relative amount of different
proteoglycans change, may have an effect to permeability (Hewitt et al. 1989). Although
the congestion of BrM is the main reason for dysfunction of the BRB, the source of all
the debris accumulating into BrM comes mainly from the RPE and its high metabolic
activity.
Changes in choriocapillaris
During aging the density of the choriocapillaris network almost halves and the diameter
of the vessels decrease by one third, thus widening the intercapillary pillars (Ramrattan
et al. 1994). This also leads to the decrease in blood volume and flow in the choroid,
thus decreasing the transport of waste products from RPE and impairing the import of
nutrients to the RPE. (Bhutto & Lutty 2012.)
2.3.2 Age-related macular degeneration and other retinal diseases
The age-related changes in the layers of the BRB have a significant role in the develop-
ment of age-related macular degeneration (AMD). This disease causes a decline, and in
some cases, a total loss of sharp central vision. The two major forms of AMD are dry
(non-exudative) and wet (exudative) AMD. (Bhutto & Lutty 2012.) The determinants
contributing to AMD are both genetic and environmental. Mutations in certain genes are
found to increase the risk of AMD, but it most probably is a complex polygenic disor-
der. Some discovered environmental factors that increase the risk of AMD are smoking,
diet and exposure to light. (Booij et al. 2010.) Figure  2.5 shows schematically the ef-
fects of dry and wet AMD compared to normal tissue.
Dry AMD is more common and, although it causes substantial visual impairment, it
does not always lead to the loss of central vision. The formation of large drusens and ab-
normal pigmentation cause distorted and dimmed vision, and are the signs of an early
form of dry AMD. In the later stages, RPE begins to atrophy. This atrophy leads to the
loss of the RPE and thinning of the retina and finally results in the loss of central vision.
The atrophy of the RPE is related to decreased permeability of BrM. At the moment
there is no treatment to dry AMD. Dry AMD can lead to the wet form of the disease.
(Bhutto & Lutty 2012.)
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Only about 10–15 % of AMD cases are wet form. It is characterized by choroidal
neovascularization  (CNV),  which  causes  abnormal  blood  vessels  migration  through
BrM and into the retina. With no barrier between the blood circulation and retina, blood
begins to leak into the retina, causing distortions and blind spots. Central vision is lost
as the abnormal vessels eventually result in disciform scar. The main reason for CNV is
the rise of pro-angiogenic factor levels, such as VEGF, compared with anti-angiogenic
factor levels, such as PEDF and endostatin.  One factor increasing the production of
VEGF is hypoxia, which may be caused by the decrease in choriocapillaris density and
the congestion of BrM. (Bhutto & Lutty 2012.) Elastin in the EL binds endostatin and
forms one barrier against the vessel migration, so the break down of  the EL might be
one reason for CNV (Mullins & Sohn 2012). Additionally, inflammation and comple-
ment system activation are partial causes of AMD (Bhutto & Lutty 2013).
In addition to AMD, there are many other diseases that affect BRB, such as diabetic
retinopathy and some form of  retinitis pigmentosa (Thrimawithana et al. 2011). How-
ever, AMD is the most common of these diseases  (Pascolini & Mariotti 2012).
2.3.3 Prevention and treatment of retinal diseases
The efforts to prevent and treat diseases such as AMD are focused on four areas: fat me-
tabolism, oxidative stress, complement activation and VEGF induced neovasculariza-
tion. Easy ways to prevent or at least postpone AMD is to stop smoking, to have a diet
high with anti-oxidants and to wear sunglasses. (Booij et al. 2010.)
There are some drug therapies that have shown promising results against AMD. The
drug targets are for example the accumulation of retinol-based toxins into the RPE and
restoration of pro/anti-angiogenic factor imbalance. (Booij et al. 2010.) The main chal-
lenge with drug-based therapies is the delivery of the drug to the retina and RPE. BRB
forms a barrier against a drug delivered through systemic circulation. The easiest way to
avoid it is to use eye drops, but even this way, the amount of drug reaching the retina is
a very small percentage. Other viable option is intravitreal injection, with which the
drug is invasively injected straight into the vitreous. The main problem with this is the
invasive injection, which means that the drug should maintain its therapeutic concentra-
tion over a long period to minimize the number of injections. (Del Amo & Urtti 2008.)
Figure 2.5. The effects of dry (B) and wet (C) AMD to BRB compared to the normal tis-
sue (A). In dry AMD, drusens form between RPE and BrM, and in wet AMD, the chori-
ocapillaris break through BRB in neovascularization.
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There  are  two  options  for  the  drug  delivery  routes  that  include  the  permeation
through BRB: periocular drug delivery and systemic administration. The drug mole-
cules have to be lipophilic for these routes to enable the crossing of the BRB. In perioc-
ular drug delivery, the drug is either injected outside the eye or a drug-releasing implant
is  positioned  next  to  it,  usually  in  the  posterior  segment.  With  these  methods,  the
choroidal blood circulation forms an additional barrier against the delivery. Systemic
delivery is also challenging, as large concentrations are needed to enable the sufficient
drug concentration in the retina. (Ranta et al. 2010.)
Another way to restore the functionality of BRB is to use tissue engineering.  RPE
transplantation has shown some success in animal models, but the main remaining chal-
lenges are  the restoration of  the RPE-retina interactions  and re-establishment  of the
BRB (Bhutto & Lutty 2012). One promising cell source for this application is human
embryonic stem cells, which can be differentiated towards the RPE direction. The prob-
lem with the earlier studies using a stem cell derived RPE cell as cell transplants was
that cell were injected only as a suspension into the subretinal space, which did not lead
to normal epithelial structure. The use of biodegradable scaffolds with cells has proven
to be a better alternative, and the search for a good biomaterial is underway. (Hynes &
Lavik 2010.)
The main interest in retinal repair is directed towards the RPE and photoreceptor
cells. However, the main site of AMD pathology is BrM. Booij et al. (2010) lists two
options for local BrM therapy, which are the removal of the pathogenic compound from
the BrM or natural bioremediation by using enzymes to restore the BrM functions.
2.4 Epithelial transport and permeability research
Certain molecular properties govern which of the two pathways – paracellular or tran-
scellular –  does a molecule take through an epithelium. Molecules can move through
epithelium either  by passive  or  active  transport.  In  passive  transport,  the  molecular
movement is passive, non-specific and its direction is governed by the electrochemical
gradient of the molecule. With active transport, on the other hand, molecules are trans-
ported to a specific direction while consuming energy. In addition to the epithelial trans-
port properties, this section also introduces the methods usually used to measure the
BRB permeability.
2.4.1 Molecular characteristics
Important molecular characteristics affecting transport through an epithelium are mole-
cule's size, charge and lipophilicity (Ho et al. 2003). The size of the molecule can be ex-
pressed in many ways:  with radius,  molecular  mass or  molecular  volume.  Different
methods of determining the molecule's radius are reviewed later.
Molecular charge is based on the pKa values of the functional groups in the mole-
cule structure and the surrounding pH. If pH is below the pKa value of a function group,
it is in its protonated form. For acidic groups, this means positive charge and for basic
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groups neutral form. When pH is above the pKa value, the functional groups are depro-
tonated,  meaning  neutral  for  acidic  groups  and  negative  for  basic  groups.  (Nelson
2008.)
Lipophilicity, or hydrophobicity, describes how well a molecule mixes with water,
and it is based on the molecule's ability to form hydrogen bonds with water molecules.
The more lipophilic the molecule, the less likely it is to form these bonds and thus to
mix with water, and vice versa. Lipophilicity can be expressed by two parameters: a
partition coefficient and distribution coefficient. They both describe the molecule's par-
titioning between aqueous and hydrophobic phases in equilibrium. The partition coeffi-
cient is the relationship between the non-ionized molecule concentration in a hydropho-
bic phase to that of the aqueous phase. Therefore, a higher partition coefficient refers to
higher lipophilicity. (Mälkiä et al. 2004.)
The distribution coefficient  includes  also  the  ionized species,  and it  has  smaller
value than the partition coefficient, as ionized species tend to remain in the aqueous
phase. The level of ionization depends on both the molecule's pKa value and the sol-
vent's pH. The hydrophobic phase is usually represented by octanol, and partition and
distribution coefficient are expressed as log P and log D, respectively. Logarithmic scale
is used as the size differences between values can be large. (Mälkiä et al. 2004.) Mole-
cules with log  P < 1 can be considered hydrophilic and log  P > 2.5 highly lipophilic
(Kadam et al. 2011). In this thesis, partition and distribution coefficients are denoted as
log  KP and log  KD, respectively, to prevent confusion with permeability and diffusion
coefficients discussed later.
2.4.2 Epithelial transport
Movement  through  the  paracellular  pathway  is  always  passive,  but  the  movement
through the transcellular pathway is more complex, as there are three main mechanisms
for it. First of all, molecules can diffuse passively across the cells with two mechanisms.
Molecules can permeate straight through the cell membrane, cell cytoplasm and other
cell membrane. The second mechanism is to partition into the hydrocarbon core of the
cell membrane and to diffuse within it to the other side of the cell. The third and more
active mechanism is carrier-mediated transport, which is done by two types of trans-
membrane proteins: channels and transporters. (Ho et al. 2003.) Channels are a form of
passive transport, as they only facilitate the diffusion across the plasma membrane along
the molecule's or ion's electrochemical gradient. Transporters function by changing their
conformation while transporting molecules across the membrane. The transport may be
passive along the molecule's electrochemical gradient or active against it. The energy
for active transport comes from the movement of other molecules, known as coupled
transport, ATP or light energy. Coupled transport is usually driven by the electrochemi-
cal gradient of ions, such as Na+. (Alberts et al. 2008.) As a fourth mechanism, the mol-
ecules can be transported using vesicles, a process known as transcytosis, and it may be
specific or non-specific. (Ho et al. 2003.) The different mechanisms of epithelial trans-
port are summarized in Figure 2.6.
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The pathway a molecule takes across an epithelium depends on its physicochemical
properties. Active transport is always specific to a molecule, depending on its specific
interactions with the transporter, whereas passive movement is non-specific. Also, mole-
cules transported actively do move passively across an epithelium. As the present work
is only concerned with the passive movement of molecules, the active transport mecha-
nisms are excluded from the following discussion.
The size of the molecule restricts the passive diffusion through both the paracellular
and transcellular pathways. Small molecules can diffuse through the small structural TJ
pores and larger ones through the dynamic strand breaks (Anderson & Van Itallie 2009).
The diffusion through the transcellular pathway is also dependent on the molecular size.
It defines how large opening there must be in the cell membrane for the molecule to dif-
fuse through. Molecules that have molecule mass under 400 Da  – which makes them
smaller than lipids  – can cross the membrane through the small gaps formed between
fluctuating lipids. Molecules larger than this diffuse slower as a larger and energetically
more unfavorable gap must be formed between the lipids. (Mitragotri 2003.)
The lipophilicity of the molecule has no effect on the paracellular pathway, as mole-
cules do not cross any lipophilic barriers. However, in the transcellular pathway it has a
major role. The hydrocarbon core of the cell membrane greatly restricts the diffusion of
hydrophilic molecules, whereas for lipophilic molecules this is the favored pathway.
The permeation of hydrophilic, and especially charged, molecules across the cell mem-
brane is energetically very unfavorable. As a basic rule, small and hydrophilic mole-
cules permeate through the paracellular pathway, and larger and lipophilic molecules
through the transcellular pathway. In addition to the permeation across the cell mem-
brane, lipophilic molecules can remain inside the membrane and diffuse within the hy-
drocarbon core around the cell cytoplasm. In this case the transmembrane proteins, such
as the TJ claudins, hinder the diffusion. (Ho et al. 2003.)
Melanin pigment in the RPE cells contributes an additional barrier to the transcellu-
lar pathway. It is fairly well established that lipophilic and basic drugs tend to bind re-
versibly to melanin. The binding interactions usually arise from electrostatic and van
Figure 2.6. The different mechanisms of epithelial transport. A: Paracellular transport;
B: Transcellular transport within the hydrocarbon core; C: Transcellular through the
cytoplasm; D: Facilitated diffusion through the channels; E: Active transport using en-
ergy or coupled transport; F: Transcytosis.
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der Waals forces. (Leblanc et al. 1998.) Lipophilicity is one major component influenc-
ing the molecule's  binding affinity,  but correlations between the two alone are quite
weak (Kadam & Kompella 2010). Also, there are differences in binding affinities be-
tween synthetic melanin and natural bovine ocular melanin (Pitkänen et al. 2007), and
natural melanin from Sepia officinalis and porcine eyes (Pescina et al. 2012).
2.4.3 Studying the BRB permeability
There are a few different ways to study the permeability in eyes. Some methods can be
utilized in vivo and some in vitro. Clinically the permeability can be measured by vitre-
ous fluorometry. In this method, fluorescein is administered to systemic circulation and
the permeated concentration is measured from vitreous using a fluorometer. (Cunha-Vaz
2004.) Another way is using a so-called retinal uptake index, analogous to a more com-
monly used brain uptake index. Tracer molecules are injected into test animals, after
which they are sacrificed and the tissues in interest are removed. The concentration in
the retina is then compared with the injected concentration. (Hosoya et al. 2010.) The
problem with above methods in relation to the present study is that the tracer molecules
can permeate into the retina through both the outer and inner BRB. Some studies utilize
tracer molecules that can be seen using an electron microscope, like ferritin. After injec-
tion and sacrifice, thin sections of BRB are prepared to observe the permeability qualita-
tively. (Essner & Gordon 1983.)
More common way of measuring the permeability of a tissue is to use a diffusion
chamber, which can be used study molecule permeation through excised tissues in vitro.
The basic idea of a diffusion chamber is to place a planar tissue, usually an epithelium,
so that it separates a chamber into two half-chambers (Clarke 2009). This method is
widely used to measure the permeability of BRB and different parts of it (Hussain et al.
2002; Hillenkamp et al. 2004; Pitkänen et al. 2005; Cheruvu & Kompella 2006; Kadam
et al. 2011). The permeated concentration can be measured by different methods: UV or
fluorescence detectors (Hussain et al. 2002; Pitkänen et al. 2005; Cheruvu & Kompella
2006), mass spectrometry (Kadam et al. 2011) or scintillation counter with radio-labeled
tracers (Hillenkamp et al. 2004; Cheruvu & Kompella 2006). In addition to the molecu-
lar permeability measurements, TER is sometimes measured during the experiments.
This is done to monitor the RPE cell viability and quality of the BRB. (Hillenkamp et
al. 2004; Pitkänen et al. 2005)
Depending on the properties of  the BRB or its parts studied, the used molecules
vary. Some basic molecules used to study the general permeability are fluorescent trac-
ers, such as fluorescein (Cheruvu & Kompella 2006), carboxyfluorescein (Pitkänen et
al. 2005) or Rhodamine tracers (Steuer et al. 2005; Cheruvu & Kompella 2006). The
permeated concentration is easily determined using a fluorometer. When studying the
influence of the molecular size on permeation, series of differently sized but otherwise
similar molecules are used. Usually used molecule series are FITC-dextrans (fluorescein
isothiocyanate) (Pitkänen et al. 2005) and amino acids (Hussain et al. 2002). The FITC-
dextrans  are  branched  polysaccharide  chains  and have  a  size  scale  of  over  1  kDa,
20
whereas amino acids are around 100-200 Da and have more compact conformation. To
study the effect of lipophilicity on the permeability, usually β-blockers are utilized. This
is because they have similar molecular masses and pKa values, but a wide range of dif-
ferent lipophilicities (Kadam & Kompella 2009). Studies using β-blockers (Pitkänen et
al. 2005; Kadam et al. 2011) measure the permeability of all the β-blockers simultane-
ously, a method known as the cassette analysis, as this saves time and effort. However,
when using a mixture of β-blockers, they have to be separated from each other during
the analysis. This is usually done using high-performance liquid chromatography, which
is found to be a good method for the separation (Ranta et al. 2002; Kadam & Kompella
2009).
2.4.4 Diffusion chamber
In a diffusion chamber, a planar tissue or cell layer on biomaterial insert is placed be-
tween two half-chambers, as schematically shown in Figure 2.7. One of the half-cham-
bers (donor chamber) is filled with a solution including the studied drug molecules and
the other (acceptor chamber) is filled with a solution without the drug. (Li et al. 2004.)
By placing the epithelium between the two chambers, the transport from one chamber to
the other takes place only through it. To enable this, the system has to be tight, so there
is no leak from chamber to the other through any other pathway than the epithelium.
The drug concentration in the acceptor chamber can then be studied by the analysis
techniques discussed earlier.
Although there are different forms of diffusion chambers, the basic principles are the
same. Some chambers include perfusion on both sides of the tissue instead of the static
fluids. (Li et al. 2004.) One type of diffusion chamber is called Ussing chamber, which
is largely used  for this  kind of studies, but especially to measure TER of  the BRB.
Figure 2.7.  A schematic presentation of the function of the diffusion chamber. The drug
solution is placed into the donor chamber and a solution without the drug in the accep-
tor chamber. From the donor chamber the drugs diffuse through BRB and a possible in-
sert into the acceptor chamber. Samples are taken from the acceptor chamber and ana-
lyzed to produce the permeability data.
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(Clarke 2009.) Depending on the type of the chamber, different kind of tubing, stirring
systems and electrodes are connected to the half-chambers (Li et al. 2004). The elec-
trodes  are connected to both sides of the epithelium, so that the TER over it can be
measured. TER is used to monitor the quality of the epithelium as well as the tightness
of the measurement system. (Griep et al. 2013.)
Although the diffusion chambers provide a good basic platform for the study of the
transport  properties  of  tissues,  there are  issues  with the current  diffusion chambers.
Problems with some currently available chambers are the large tissue area and chamber
volumes. By miniaturizing the whole system, the needed tissue areas and chamber vol-
umes  can  be  decreased.  This  means that  smaller  tissue  pieces  can  be  used  and the
amount of solutions and drugs decrease. (Griep et al. 2013.) Perfusion used in some
chambers helps to minimize the hydrostatic pressure of large chamber and thus prevent
tissue damage (Li et al. 2004).
2.5 Physics of diffusion and permeability
Diffusion is one of the basic methods of movement in the molecular scale. This section
describes the physical basis of diffusion and the equations trying to capture its essence.
In addition to diffusion, also permeability over barriers and hindered diffusion within
different geometrical surroundings are represented.
2.5.1 Diffusion
Diffusion is a phenomenon that describes passive movement of molecules usually in liq-
uid or in gas. The driving force of diffusion is the random thermal motion of the sur-
rounding solvent or gas molecules.  Diffusion is  an important process in  the  cellular
world, as it is a method of transport without any consumption of chemically stored en-
ergy. There are two scales that diffusion can be described in. In the molecular scale, the
random motion of an individual molecule can be studied and modeled, and in the larger
scale, diffusion is a process which leads to a complete mixing of molecules with con-
centration differences – or  an  equilibrium. (Nelson 2008.) The rate of diffusion is de-
noted with diffusion coefficient D, which has a unit of m2 s−1. The bigger the D is, the
larger is the diffusion rate. 
In the molecular scale the random motion of one molecule (referred as a solute parti-
cle from here on) is created by the interactions between the solvent molecules and the
solute particle. As the small solvent molecules fluctuate due to the thermal energy and
collide with the larger solute particle, they exert a small force on it. Generally, these
small collisions have a little effect, as the size difference between the solute particle and
small solvent molecules is large, and they tend to cancel each other out. Thus the parti-
cle remains stationary. However, at some time points a net force exists towards a ran-
dom direction and the particle moves. This movement continues until, after a while, an-
other net force is exerted towards another random direction. (Nelson 2008.) This motion
can be described as a random walk and it is known as the Brownian motion, named after
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a 19th century Botanist Robert Brown, who noticed the random motion of pollen grains
suspended in water (Brown 1828).
Brownian motion can be modeled  in many ways, most notably with equation de-
rived by Albert Einstein in 1905. The small collisions creating the movement of the
solute particle also diminish it as they generate resisting frictional force. Einstein's the-
ory does not account the individual collisions, but represents the solvent with this force.
Einstein related the parts creating and diminishing the diffusion to one equation, known
as Einstein's relation or fluctuation-dissipation theorem
ζ D=k B T , (2.1)
where ζ is the viscous friction coefficient, which is the relation of the frictional force to
the particle's drift velocity (N s m−1), kB is Boltzmann's constant (1.38×10−23 J K−1) and T
is the absolute temperature (K). This relation is universal, as it does not depend on the
solute particle or solvent. (Nelson 2008.)
To relate the diffusion coefficient to the particle, especially  to its size, the viscous
frictional coefficient has to be defined. The most  commonly used form of this coeffi-
cient was derived by Sir George Stokes for a rigid spherical particle diffusing in a con-
tinuum of solvent, and it is known as Stokes' law
ζ=6πηr s, (2.2)
where η is the solvents dynamic viscosity (Pa s) and rs is the solute particle radius (m).
The value of η at  37 °C is 6.92×10−4 Pa s. Equations (2.1) and (2.2) can be combined
into Stokes-Einstein equation
D=
k B T
6π η rSE
, (2.3)
where the subscript of  rSE denotes that this is Stokes-Einstein radius. As can be seen
from Equation (2.3), a small particle has large D and vice versa. Nowadays it is possible
to measure the diffusion coefficients and Equation (2.3) is usually used to calculate the
size of the solute particle. (Nelson 2008.)
It is important to notice that the Stokes-Einstein radius does not always correspond
to the actual size of the molecule, just the radius of a spherical particle with the diffu-
sion coefficient D. There are many other and more complex approximations for this re-
lationship, but Equation (2.3) is very simple and quite accurate. The important assump-
tions of Stokes' law are that the particle is spherical and has a radius of more than five
times the radius of the solvent molecules. (Cussler 2009.) These assumptions are good
for large globular proteins, but not for linear proteins or small drug molecules. The as-
sumption of a spherical particle is seldom very accurate, but it is a mandatory simplifi-
cation, as it enables the description of solute particle's size with one parameter and the
utilization of spherical symmetry. For particles smaller than five times the radius of the
solvent molecule, Equation (2.3) fails.
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This  size restriction can be bypassed by using Sutherland correlation,  which as-
sumes that – contrary to Stokes-Einstein equation – the solvent molecules can slip past
the surface of the particle (Sutherland 1905)
D=
k BT
4π η r Su
, (2.4)
where the subscript of rSu emphasizes the difference with Stokes-Einstein radius. A com-
mon collective name for rSE and rSu is a hydrodynamic radius, but it is important to dif-
ferentiate them as they are meant for different molecular size scales.
The diffusion covered so far describes the diffusion of one average particle in a con-
tinuum of solvent. In the larger scale, including multiple particles and concentration gra-
dients, diffusion levels out the gradients and eventually leads to a complete equilibrium.
Basically, diffusion erases order, so it has entropic nature. Diffusion in this scale is de-
scribed by Fick's laws of diffusion, named after Physicist Adolf Fick. Fick's first law
states that the number of solute particles diffusing per unit area per unit time, or diffu-
sional flux, relates to the particle concentration gradient according to Equation
J=−D ∇ c, (2.5)
where J is the diffusional flux (mol m−2 s−1) and c is the concentration (mol m−3). The
symbol  denotes the gradient and represents a partial derivation in three directions. Ba∇ -
sically, Equation (2.5) states that the flux is directed towards the decreasing concentra-
tion with the rate defined by D. The basic reason behind the direction of the flux is the
fact that there are more particles in the domain with high concentration diffusing to-
wards the low concentration domains than in the other direction. Fick's first law as-
sumes steady-state conditions, in which the flux is constant. Fick's second law omits the
flux altogether and defines the rate of concentration change as
∂c
∂ t
=D ∇2 c. (2.6)
This equation is also known as the diffusion law. (Nelson 2008.)
It is important to notice that diffusion coefficients in Stokes-Einstein or Sutherland
equations are limited to infinitely dilute solutions, as they do not take into account the
interactions between solute particles. Diffusion coefficients in liquids vary with the con-
centrations, sometimes by several hundred percents. (Cussler 2009.) The assumption of
dilute concentration is usually made in mathematical models, although it is not neces-
sarily always very accurate (Cu & Saltzman 2009).
2.5.2 Permeability
In cases where the particle diffuses through a barrier, for example an epithelium, a per-
meability coefficient is usually used instead of the diffusion coefficient. The permeabil-
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ity coefficient is more case-specific and it is defined from the diffusion coefficient ac-
cording to Equations
P=
DB ,eff
l B
, (2.7)
where
DB ,eff=DBΦB (2.8)
and P is the permeability coefficient (m s−1),  DB,eff is the effective diffusion coefficient
within the barrier (m2 s−1), lB is the barrier thickness (m), DB is the diffusion coefficient
within the barrier (m2 s−1) and ΦB is the partition coefficient between the solvent and the
barrier. Usually, the experimentally measured permeability coefficients are denoted as
apparent (Papp) or effective (Peff) to highlight their uncertainty and dependence on exper-
imental conditions. (Brodin et al. 2009.) The partition coefficient describes the amount
of solute inside the matrix in relation with the free solution – that is, how favorable the
matrix environment is for the molecule. Basically, it is analogous to the partition coeffi-
cient describing lipophilicity.
With permeability, Equation (2.5) can be written as
J=−P ∇ c
l B
, (2.9)
which is analogous to Ohm's law, as J corresponds to current and ∇c to potential differ-
ence.  This  means  that  permeability  is  analogous  to  electrical  conductivity.  (Cussler
2009.) Thus when there are different diffusion pathways and diffusion barriers within a
pathway, the permeabilities can be thought of as being connected in parallel or in series.
If  n number of pathways are connected in parallel,  the individual permeabilities are
combined to total permeability by using Equation
P tot=∑
i=1
n
P i. (2.10)
Because in this case the permeabilities are additive, the relationship is straightforward:
if there are pathways with permeabilities in different orders of magnitude, the pathway
with the highest permeability dominates. (Yu & Amidon 2000.) For example the para-
cellular and transcellular permeabilities can be combined using this equation.
If  n number of diffusion barriers  are  connected in series – arranged in successive
manner – the total permeability is calculated with Equation
1
P tot
=∑
i=1
n 1
P i
. (2.11)
When connected in series, the barrier with the lowest permeability mainly defines the
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total permeability. (Yu & Amidon 2000.) The lateral space and TJs are connected in se-
ries in the paracellular pathway, the latter dominating with its low permeability.
2.5.3 Hindered diffusion
Diffusion taking place within the permeability barrier is slower than in free solution, be-
cause of the barrier structures hindering it. The interactions between the barrier struc-
tures and the solute particle can be divided into three types: hydrodynamic, steric and
electrostatic.
Hydrodynamic interactions are mechanical interactions between the solute particle
and structures that are mediated by the solvent. They enhance the frictional drag felt by
the diffusing particle, thus decreasing the diffusion rate as seen from Equation (2.1).
Also,  the structures  serve as  steric  obstacles that  increase the diffusion path length.
(Amsden 1998.) In addition to these more mechanical interactions, there may be electro-
static interactions that cause attraction or repulsion between the particle and its sur-
roundings, thus affecting the diffusion rate.
Models for hindered diffusion within three different geometrical structures – slit,
pore and fiber matrix – are presented next. Their geometries are presented in Figure 2.8.
Slit model
The basic geometry of the slit model is a space with a width of 2Ws between two paral-
lel surfaces, as shown in Figure 2.8A. Essentially, the slit model is a modified version of
Equation (2.7), as the permeability coefficient of the slit is given by Equations
P=
ϵs D0 H s(λ s)
l s , (2.12)
where
λ s=
r s
W s
(2.13)
Figure  2.8. The geometrical idea of slit model (A), pore model (B) and fiber matrix
model (C). (Ws: slit half-width; ls: slit length; rp: pore radius; lp: pore length; rs: solute
particle radius; rf: fiber radius)
26
and ϵs is the relative surface area of the slit, D0 is the free diffusion coefficient (m2 s−1),
Hs(λs) is the hindrance factor in a slit, ls is the slit length (m) and Ws is the slit half-width
(m). (Ho et al. 2003). The hindrance factor Hs(λs) basically describes the sum of the par-
titioning into the slit, and hydrodynamic as well as steric interactions within the slit it-
self  (Dechadilok & Deen 2006).  There are many different approximations for  Hs(λs)
with different value ranges of λs. The most accurate one was derived by Dechadilok &
Deen (2006) and it is accurate within the range of 0 ≤ λs ≤ 0.80:
H s(λ s)=1+
9
16
λ s ln λ s−1.19358λ s−0.4285λ s
3−0.3192λ s
4
+0.08428λ s
5
. (2.14)
Pore model
This model is very similar to the slit model, but the pore is formed by a cylinder, as
shown in Figure 2.8B. Again, this is a modification of Equation (2.7) and is given as
P=
ϵ p D0 H p(λ p)
l p
, (2.15)
where
λ p=
r s
r p
(2.16) 
and ϵp is the relative surface are of the pores, Hp(λp) is the hindrance factor in a pore, lp
is the pore length (m) and  rp is the pore radius (m) (Ho et al. 2003). Again, there are
many different approximations for the hindrance factor in pores. Dechadilok & Deen
(2006) derived one with a good accuracy range of 0 ≤ λp ≤ 0.95:
H p(λ p)=1+
9
8
λ p ln λ p−1.56034λ p+0.528155λ p
2+1.91521λ p
3
−2.81903λ p
4+0.270788λ p
5+1.10115λ p
6−0.435933λ p
7
. (2.17)
Fiber matrix model
The fiber matrix model describes diffusion within a randomly oriented fiber matrix, as
shown in Figure 2.8C. This theory was proposed by Ogston (1958) and it describes the
polymer matrix with only the radius and fiber volume fraction. As shown in Equation
(2.8), the partition coefficient and diffusion coefficient inside the matrix has to be de-
fined to calculate the effective diffusion coefficient.
The partition coefficient for an uncharged, spherical particle in a randomly oriented
fiber matrix can be calculated with Equation
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Φm=exp[−ϕ f(1+ r sr f )
2], (2.18)
where φf is the fiber volume fraction and rf is the fiber radius. Equation (2.18) is limited
to dilute solutions, as it does not include the intermolecular interactions. (Ogston 1958.)
Later Ogston et al. (1973) derived an equation for the diffusion coefficient within the
matrix. The equation tends to overestimate as it includes steric interactions, completely
ignoring the hydrodynamic interactions (Johnson et al. 1996).
The diffusion coefficient within the matrix includes the hydrodynamic and steric in-
teractions between the particle and the matrix. Brady (1994) suggested a so-called effec-
tive medium model, which divides the two interactions into two separate factors
Dm
D0
=H m S m, (2.19)
where Dm is the diffusion coefficient within the matrix (m2 s−1), and Hm and Sm are the
hydrodynamic and steric interactions, respectively.
There are some different results for the hydrodynamic interactions between a spheri-
cal  particle  and randomly oriented fiber  matrix.  A widely used one was derived by
Phillips et al. (1989) and it relates the hydrodynamic interactions to the matrix fluid per-
meability, called Darcy permeability. The problem with this model is that the Darcy per-
meability of the matrix must be known, or at least approximated. To counter this fact,
Clague & Phillips (1996) derived an equation relating the interactions only to the fiber
volume fraction, and fiber and solute particle radii
H m=exp(−a ϕ f
ν ), (2.20)
where a and ν are fitted parameters and dependent of rf and rs. Amsden (1998) fitted the
parameters using literature data of diffusion in hydrogels as
a=π (2.21)
and
ν=0.174 ln(59.6 r fr s ). (2.22)
The  two  models  have  been  compared  with  varying  results  (Amsden  1998;  Phillips
2000). When  rs and  rf have similar magnitude, both models have practically identical
behavior across the whole volume fraction range. However, when the fiber radius is
much larger than that of the solute particle, their behavior is very different.
The steric interactions can be calculated by using an equation derived by Johansson
& Löfroth (1993) for diffusion through straight, randomly oriented fiber network, be-
cause they ignored the hydrodynamic interactions:
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Sm=exp(−0.84 f
1.09) (2.23)
and
f =ϕ f (1+ r sr f )
2
, (2.24)
where  f is the adjusted fiber volume fraction. Basically Equation (2.24) describes the
volume fraction of fibers with a radius of  rs + rf. Equation (2.23) was derived using
Brownian dynamic simulations and it is valid when f < 3 (Johansson & Löfroth 1993).
There are also other results for  S with different fiber arrangements, for example those
derived for hexagonal and square arrays of cylinders by Perrins et al. (1979).
In addition to the hydrodynamic and steric interactions, there can be electrostatic in-
teraction between the solute particles and fibers. In ionic solutions, charged surfaces are
surrounded by ions with an opposite charge. This ion cloud screens the surface charge,
and Debye screening length characterizes the distance after which the surface seems
neutral. (Nelson 2008.) Debye screening length depends on the ionic strength of the so-
lution. Electrostatic interactions lose their significance as the radius of the fiber is much
larger than Debye screening length. (Stylianopoulos et al. 2000a.) There are small elec-
trostatic interactions even though other object is uncharged, as it still influences the ion
cloud surrounding the charged object (Johnson & Deen 1996).
To incorporate the electrostatic interactions, the basic fiber matrix theory has to be
modified. Johnson et al. separately measured the effective diffusion and partition coeffi-
cients  of molecules  with different  charges  diffusing through agarose gel.  They con-
cluded that the electrostatic interactions mainly affect the partition coefficient, not the
diffusion coefficient within the matrix. (Johnson et al. 1995.) The mathematical model
to predict this behavior was constructed by Johnson & Deen (1996). Equation (2.18)
was originally derived from Equations
Φm=∫
0
∞
g (h)dh (2.25)
and
g (h)=
2ϕ f (h+r s+r f )
r f
2 exp [−ϕ f (h+r s+r f )2r f2 ], (2.26)
where h is the separation distance between the particle and a fiber (m) (Ogston 1958).
To include the electrostatic interactions into the partition coefficient, Johnson & Deen
(1996) introduced Boltzmann factor into Equation (2.25) to describe the relative proba-
bility of different energy states between the solute particle and the fiber so that
Φm ,e=∫
0
∞
g (h)exp (−E (h))dh (2.27)
29
and
E (h)=
(RT /F )2ϵr s
k B T
ΔG(h), (2.28)
where R is the universal gas constant (8.31 J mol−1 K−1), F is Faraday constant (9.65×104
C mol−1), ϵ is the solvent's absolute permittivity (F m−1) and ΔG is the change in free en-
ergy (J).  The absolute permittivity is defined as ϵ = ϵ0ϵr, where ϵ0 is the vacuum permit-
tivity (8.85×10−12 F m−1) and ϵr is the relative permittivity, which is 74.2 for water at 37
°C. The change in free energy can be divided into three components: the first describing
the free energy change between the particle and fiber (ΔGsf) and the other two describ-
ing the changes in the ion clouds surrounding the particle (ΔGs) and fiber (ΔGs) result-
ing in Equation
ΔG (h)=ΔG sf (h)+ΔG s(h)+ΔG f (h). (2.29)
Electrostatic interactions in ionic solutions are described by Poisson-Boltzmann equa-
tion. A linearized version of this equation was used by Johnson & Deen (1996) to deter-
mine the electrical potentials and it was solved using a finite element method. The re-
sulting expression is of the form
ΔG (μ ,τ ,β ,σ s ,σ f )=A1(μ ,τ ,β )σ sσ f +A2(μ ,τ ,β )σ s
2
+A3(μ ,τ ,β )σ f
2 , (2.30)
where
Ai(μ ,τ ,β )=aiτ
bi β c i exp (−d iμ) (2.31)
and ai, bi, ci and di are constants shown in Table 2.1. The rest of the factors in Equations
(2.30) and (2.31) are the dimensionless separation distance µ, particle radius τ, fiber ra-
dius β, particle's surface charge density σs and fiber's surface charge density σf. They are
defined by Equations
μ=hκD, (2.32)
τ =r sκD, (2.33)
β=
r f
r s
, (2.34)
σ s=
r s F
ϵR T
qA ,s (2.35)
and
σ f=
r f F
ϵR T
qA, f , (2.36)
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where κD is reciprocal of Debye screening length (m−1), and qA,s and qA,f are the particle's
and fiber's surface charge densities (C m−2), respectively. (Johnson & Deen 1996.) The
value of κD−1 is 0.79 nm in the physiological ionic strength of 0.15 M (Stylianopoulos et
al. 2010a).
The permeability coefficient of a fiber matrix barrier with a thickness of dm can be
calculated as
Pm=
Dm, eff Φm
d m
=
D0 H m S mΦm
d m
, (2.37)
where Φm is replaced with Φm,e if the electrostatic interactions are included.
2.6 Mathematical modeling
The  importance  of  mathematical  modeling  of  biological  processes  and systems  has
rapidly increased in recent years (Gavaghan et al. 2006). This section describes the ba-
sics of models, mathematical modeling and a technique known as the finite element
method.  Also,  the  current  state  of  mathematical  modeling  of  the BRB and  similar
anatomical structures are presented shortly.
2.6.1 Mathematical modeling of physiological systems
A model is a presentation of a real system. It is practically impossible to model a real
system perfectly: there has to be some approximations. A mathematical model expresses
the real system with mathematical equations. (Cobelli & Carson 2008.) Mathematical
modeling is an important tool in life sciences as it enables the study of physiological
processes and features with a reduced need to study the real system, which is in some
cases difficult and expensive as well as includes the usage of test animals. Models can
also be used to rule out some unneeded experimental studies and enable the experimen-
tal researchers to concentrate only on the important studies.
Another kind of important type of model in life sciences is an in vitro model. In an
in vitro model, a physiological system is modeled by constructing a close biological
equivalent system. In the case of the epithelial research, this usually means using cul-
tured cells to form the epithelium, as opposed to using excised tissues from test animals
or deceased humans. In vitro models allow the study of important properties of a physi-
ological system easily and decrease the need of test animals (Barar et al. 2009).
Table 2.1. The values of constants ai, bi, ci and di in Equation (2.31) (Johnson & Deen
1996).
i ai bi ci di
1 2.3523 0.7599 1.2472 1.0956
2 0.3570 0.5052 0.9512 3.7684
3 0.4473 0.9310 1.1512 2.4987
b
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Modeling of a physiological system is  quite different from modeling mechanical
systems. Physiological systems are complex, which rises for example from the number
of components, interconnectivity in the system and nonlinearity. They are also dynamic
and stochastic, so the behavior is sometimes difficult to predict. As in all models, the
real system must be simplified, only accounting the important and governing compo-
nents relating to the studied function. (Cobelli & Carson 2008.)
Models are used for different purposes and they can be categorized into four classes:
descriptive, interpretive, predictive and explanatory. Descriptive models are used to ex-
press quantitative relationships between variables with equations. For example, Stokes-
Einstein equation is a descriptive model, as it relates the diffusion rate to particle size.
Interpretive models are used to interpret experimental results using mathematical equa-
tions. Predictive models are used to predict the output of the system with a known input.
Explanatory models can be used to explain changes in a system by studying the effects
of modeling parameters linked to system properties. (Cobelli & Carson 2008.)
There are two distinct approaches to mathematical modeling. Data-driven, or black-
box modeling uses the known input and output of the system to determine a mathemati-
cal representation of the system using parameters without any connection with the real
system. This is a good approach if there is little knowledge about the system or if a
more accurate representation of the system is not needed. The other approach is to actu-
ally model the system. This approach needs prior knowledge of the system, but is gener-
ally more dynamic and related to the real system. After the model is created, it has to be
validated. This is done by comparing its behavior with the real system and, in some
cases, alternative models. Validation is also done during the model construction, as the
quality of approximations has to be determined. A complete model can be used to study
different scenarios by simulating the system response to specific inputs (Cobelli & Car-
son 2008.)
2.6.2 Finite element method
As a computational technique, the finite element method (FEM) can be used to obtain
approximate solution to engineering problems. Real systems are continuous, and it is
impossible to compute the value of a variable in every point of a volume. With FEM,
this problem is avoided by dividing the system domain into small, finite-sized elements,
so only a finite number of values have to be calculated. (Hutton 2003.)
FEM is applied to solve so-called boundary value problems, in which depending
values must satisfy the governing differential equations everywhere in a system domain
with known boundary conditions (BCs). Material properties are an important part of
FEM modeling as they define how a specific material behaves. (Hutton 2003.) For ex-
ample, when modeling diffusion as a boundary value problem, the dependent variable is
concentration, governing differential equation is Fick's second law, a BC might be that
there is no flux out of the system and material properties might be the viscosity of water
as well as diffusion coefficient of the solute.
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The elements are usually triangular in two dimensions and tetrahedral in three di-
mensions. The variables are usually calculated in the vertices of the elements, known as
nodes, and the values of all the other points in the system are approximated by interpo-
lation from the node values. The system's number of the degrees of freedom depends on
both the number of the nodes and dependent variables in the system. (Hutton 2003.)
The process of discretization is called meshing and the element structure is called a
mesh. The element number of the mesh defines the accuracy of the approximation of the
real system. By increasing the element number, the size of each element decreases and
approaches infinitesimal volume, or a point. The problem with increasing the element
number is that the amount of degrees of freedom is also increasing, thus increasing the
computational load. (Hutton 2003.)
The basic FEM modeling process is divided into three parts: preprocessing, solution
and postprocessing. Preprocessing means the definition of the model: e.g. its geometry,
material properties and BCs. In the solution phase a FEM software, like COMSOL Mul-
tiphysics, is used to compute the results. The postprocessing includes the analysis and
evaluation of the results. One important part of the postprocessing is the determination
of the result reasonability. (Hutton 2003.)
2.6.3 Mathematical models of BRB and corresponding structures
Most of the current mathematical models of  the  BRB  are so-called pharmacokinetic
models. They are constructed from anatomically-based compartments and rate constants
that describe the drug transport between the compartments (Gallo 2003). Mac Gabhann
et al. (2007) constructed a pharmacokinetic model of protein transport into the eye after
periocular injection. In their model, BRB is only represented by the RPE with just one
permeability coefficient (Mac Gabhann et al. 2007). A different approach was taken by
Amrite et al. (2008), as they simply connected sclera, choroid and RPE into one com-
partment and had rate constant for transport into and out of this compartment. Ranta et
al. (2010) related their compartmental model more to the properties of the solutes. They
used  three  different  molecule  types:  small  lipophilic,  small  hydrophilic  and  macro-
molecule. They still gave these three types constant permeability coefficients based on
in vitro and in vivo experiments.
In addition to pharmacokinetic compartmental models, there are some FEM models
of drug movement within the eye, but only few of them include BRB. Balachandran &
Barocas (2008) constructed a FEM model of periocular delivery of fluorescein into the
eye. In addition to the passive diffusion, they included the active transport of fluorescein
outwards from the eye. As their model also included the geometry of the eye, it resem-
bled more the actual physiological system. (Balachandran & Barocas 2008.)
More accurate models relating the physiocochemical properties of the diffusing mol-
ecule with the permeability have been constructed for anatomical barriers. Edwards &
Prausnitz (1998; 2001) combined physical theories into a model describing hindered
diffusion  in  the  cornea.  Their  model  consisted  of  three  parts:  corneal  endothelium,
stroma and epithelium. For the stroma they used the fiber matrix model, and both the
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endo- and epithelium were modeled with three pathways. The paracellular pathway was
modeled with the slit model and the transcellular pathway was divided into two sub-
pathways:  diffusion through the cytoplasms and diffusion within the cell  membrane
around the cytoplasm. (Edwards & Prausnitz 1998; 2001). The current models including
the BRB, their benefits and drawbacks are presented in Table 2.2.
Table  2.2. A summary of the  permeability models that include the BRB or its parts.
Please note that the last model is not of the BRB, but of cornea. 
Type Model Properties Benefits and drawbacks
Pharmacokinetic Mac Gabhann et al. 
2007
RPE presented by one 
diffusion coefficient
Simple, but no relationship 
between molecular properties 
and permeability
Amrite et al. 2008 Sclera, choroid and RPE 
form a single compartment,
rate constants for inwards 
and outwards movement
Simple, but no relationship 
between molecular properties 
and permeability
Ranta et al. 2010 RPE presented by three 
diffusion coefficient for 
three types of molecules
Simple and some relationship
between the molecular 
properties and permeability, 
but cannot be used for a 
specific molecule
FEM Balachandran & 
Barocas 2008
Transport of fluorescein 
into the eye, including 
active transport and a 
realistic geometry
More complex and includes 
the geometry, but constructed 
only for one molecule
Model based on physic-
ochemical properties 
Edwards & Prausnitz
1998; 2001: cornea
Based on the properties of 
the cornea and diffusing 
molecule
Can relate the permeability to
molecular properties, but 
quite complex
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3 MODELS OF THE BLOOD-RETINAL 
BARRIER AND HALF-PERFUSION 
CHAMBER
This thesis consists of two models. At first, a passive diffusional model across the BRB,
based on the physicochemical properties of both the BRB and diffusing molecule, was
constructed. The second model  was a FEM model of a general concept of a chamber
having a stationary fluid on one side of the BRB membrane and perfusion on the other
side.  Both models  are  mathematical  models,  can be classified as  predictive and are
based on the knowledge of the systems.
3.1 Model of the outer blood-retinal barrier (BRB model)
This model is a steady-state model of passive diffusion across the BRB. The mathemati-
cal framework and physical theories used in this model are largely based on the works
of Edwards & Prausnitz (1998; 2001), who constructed a model by combining physical
theories derived by others to predict the permeability of cornea to drug molecules. The
present model of BRB is modified in aspects related to the different structural and com-
positional features between the BRB and the cornea. Also, the behavior of the equations
used by Edwards & Prausnitz is assessed in this application and compared with alterna-
tive equations to find the most suitable ones for this model. A new feature proposed in
this BRB model is a structurally more detailed model of the TJs.
The present model is based on the BRB in the human macular region. Only the pas-
sive diffusion pathways are included and the facilitated diffusion through the RPE cell
membrane channels is ignored.  The major parts of the model are presented in Figure
3.1. The RPE consists of paracellular and transcellular pathways connected in parallel.
Further, the paracellular pathway includes the lateral space and TJs connected in series.
The transcellular pathway consists of the two cell membranes and  the cytoplasm, in-
cluding the melanin binding, connected in series. BrM includes the ICL and OCL con-
nected in series and CE only includes the fenestrations. The permeabilities of the RPE,
BrM, CE and whole BRB can be calculated as
P RPE=P para+P trans=( 1PLS + 1PTJ )
−1
+ ( 2Pmem + 1Pcyt)
−1
, (3.1)
P BrM=( 1P ICL + 1POCL )
−1
, (3.2)
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PCE=P fen (3.3)
and
P BRB=( 1P RPE+ 1P BrM + 1PCE )
−1
. (3.4)
In this chapter, the parts of the model are described. The way the geometry of the bi-
ological structure is modeled is explained at the beginning of each part. Also, the major
simplifications and reasoning behind them are given. Next, the way that Edwards &
Prausnitz modeled the corresponding part of the cornea and the equations they used are
introduced. The way the present model calculates the diffusion in the geometry in ques-
tion is then described.
Figure  3.1. The main permeability components of BRB. The molecules first permeate
through  the  choriocapillaris  endothelial  fenestrations  (Pfen),  and  then  through  OCL
(POCL) and ICL (PICL) of BrM. RPE is divided into two pathways: paracellular and tran-
scellular. In the paracellular pathway the solute molecules permeate through the lateral
space (PLS) and TJs (PTJ), and in the transcellular pathway through the cell membrane
(Pmem),  cytoplasm including the effect of melanin (Pcyt) and cell membrane (Pmem). To
calculate the total BRB permeability, Equations (2.10) and (2.11) are used to combine
different permeabilities in parallel or in series.
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3.1.1 Retinal pigment epithelium
RPE is modeled by connecting the paracellular and transcellular diffusion pathways in
parallel. The geometrical idea of the model is presented in Figure 3.2. The cells are or-
ganized into a hexagonal array leaving a small gap between them as shown in Figure
3.2A. The main assumption of this model is that the solute molecules can only diffuse
along one pathway.  Thus, molecules cannot diffuse into lateral space and change the
pathway by transversing the lateral cell membrane. The microvilli and basal infoldings
are also ignored.
Edwards & Prausnitz modeled two cell layers: corneal epithelium and endothelium.
Their paracellular pathway consisted of a lateral space connected in series with a nar-
rower part, representing the TJs. For the transcellular pathway, they included two per-
meation pathways. In the first one the molecules permeate through the basal cell mem-
brane, cytoplasm and apical cell membrane.  In the second one the molecules partition
into the cell membrane's hydrocarbon core and diffuse around the cytoplasm within the
membrane and partition out of the membrane in the apical side. Edwards & Prausnitz
used the slit model for the lateral space (Equations (2.12) and (2.13)) with different and
less accurate equation for the hindrance factor Hs(λs). Other equations used by Edwards
& Prausnitz or based on equations used by them are Equations (3.5), (3.10), (3.11), and
(3.12). (Edwards & Prausnitz 2001.)
Paracellular pathway
The paracellular pathway is modeled with the lateral space and TJs connected in series,
and the basic geometry is presented in Figure 3.2B. The lateral space is modeled with
the slit  model (Equations from (2.12) to  (2.14)).  The parameters  needed for the slit
model are the relative surface are of the lateral space, lateral space length and lateral
space half-width WLS (m). The effective lateral space length is τLShLS, where τLS is the lat-
eral space tortuosity and hLS is the lateral space length (m). Parameter hLS can be defined
as hRPE − hTJ, where hRPE is the RPE cell height (m) and hTJ is the TJ region height (m).
Figure 3.2. The basic geometrical idea of the RPE model. A: The hexagonal array of
RPE cells (dRPE: RPE cell flat-to-flat diameter; hRPE: RPE cell height). B: The lateral
space and TJs between the RPE cells (hTJ: TJ region height; τLS: lateral space tortuos-
ity; hLS: height of the lateral space without the TJ complex; WLS: half-width of the lat-
eral space). C: A section of the TJ structure in the model without the other cell mem-
brane. Each strand (darker parts) is represented with an intact part with small pores
and an open part  reflecting  the  strand breaks.  (dTJss:  TJ  strand  separation;  lTJs:  TJ
strand height ; WTJ: TJ region half-width).
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The relative surface area of the lateral space, ϵLS, for Equation (2.12) can be determined
by multiplying the width of the slit with the length of the cell boundaries per unit area
(Edwards & Prausnitz 1998). For hexagonal cells this can written as
ϵLS=2W LS lcb=2W LS[( 1√3d RPE2 / 2)(12√33 d RPE2 )12 ], (3.5)
where lcb is the cell boundary length per unit area (m m−2) and dRPE is the hexagonal cell
flat-to-flat diameter (m). The part in the brackets is simply the cell density multiplied by
the circumference of one cell and divided by two to encounter the fact that all bound-
aries between two cells are calculated twice.
The basic TJ geometry used is shown in Figure 3.2C. The TJ model proposed here is
novel, and it  applies the slit pore model already utilized for the lateral space and pore
model (Equations from (2.15) to (2.17)). The narrow part in the lateral space represents
the TJ region, where the TJ complex resides. Each strand is modeled with an intact part
and open part, which represent the dynamic breaks. The slit model is used to model the
diffusion in the open parts and in the parts between two strands. The parameters needed
for the slit model are the TJ region half-width WTJ (m), TJ strand height hTJs (m) for the
open parts and TJ strand separation dTJss (m) as well as the relative surface areas of the
open parts ϵTJo and space between the strands ϵTJss. Parameter ϵTJo is calculated as
ϵTJo=2W TJ l cbϵopen, (3.6)
where lcb is calculated as in Equation (3.5) and ϵopen is a parameter describing the open
part size. Although the web-like structure of the strands is omitted in the geometry, its
influence is incorporated into parameter ϵopen, as the structure greatly hinders the diffu-
sion rate. Parameter ϵTJss is calculated as in Equation (3.5) with WTJ.
The intact part has periodically-located small structural pores through it, which are
modeled using the pore model. Parameters needed for the pore model are the TJ pore ra-
dius rTJp (m), relative surface are of the TJ pores ϵTJp, and hTJs. Parameter ϵTJp can be cal-
culated as a multiplication of the area of one pore and the number of pores per unit area
ϵTJp=π r TJp
2 l cb (1−ϵopen)
d TJp
, (3.7)
where dTJp is the pore separation (m).
The permeability of each strand can be calculated by connecting the intact and open
parts in parallel
PTJs=PTJp+PTJo, (3.8)
where  PTJp is the TJ pore permeability  (m s−1) and  PTJo is the open part permeability
(m s−1). The permeability coefficient of the space between two strands,  PTJss (m s−1), is
also calculated with the slit model, with the relative surface area of the narrowed TJ re-
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gion ϵTJss calculated as in Equation (3.5). Now the total TJ permeability coefficient is
calculated as
PTJ=( nTJsPTJs+(nTJs−1)PTJss )
−1
, (3.9)
where nTJs is the strand number and PTJss (m s−1) is the permeability of the space between
two strands. The paracellular permeability coefficient is calculated as shown in Equa-
tion (3.1).
Transcellular pathway
The transcellular  pathway is  modeled with two cell  membranes and cytoplasm con-
nected in series. The plasma membrane permeability was modeled by Edwards & Praus-
nitz (2001) by utilizing the experimental result of red blood cell membrane permeabil-
ity,  measured  by Lieb  & Stein  (1986).  Lieb  & Stein defined the  permeation across
plasma membrane as
Pmem=Pmem
0 10−mv V , (3.10)
where Pmem has units of cm s−1, P0mem is the membrane permeability of a theoretical, in-
finitely small molecule (cm s−1), mv is the membrane volume selectivity (mol cm−3) and
V is the van der Waals volume of the diffusing molecule (cm3 mol−1). The value of mv
for red blood cell was found to be 0.0516 mol cm−3. (Lieb & Stein 1986.) Edwards &
Prausnitz used the test molecule data given in Lieb & Stein (1986) to fit the value of
P0mem as
log(Pmem
0 )=A log (K D)+B, (3.11)
where KD is the octanol/water distribution coefficient, and A and B are constants with
the values 1.323 and −0.834, respectively.
Two effects are taken into account in the diffusion across the cytoplasm: the intra-
cellular structures, like mitochondria and endoplasmic reticulum which hinder the diffu-
sion, and drug-binding melanin. Kao et al. (1993) determined the diffusion coefficient in
the cytoplasm to be about 25 % of the free diffusion coefficient. So, the cytoplasmic dif-
fusion coefficient is given by Equation
D cyt=0.25 D0. (3.12)
Binding to melanin can be very simply added to the model by a method recommended
by Cheruvu & Kompella (2006) for modeling the effects of binding to matrix as
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D cyt ,eff =
Dcyt
1+K a
, (3.13)
where Dcyt,eff is the effective cytoplasmic diffusion coefficient and Ka is the association
constant of the melanin binding reaction (µM−1). The cytoplasm permeability coefficient
Pcyt is calculated with Equation (2.7) with hRPE. The paracellular, transcellular and total
RPE permeability  coefficients  are  calculated  as  shown in  Equation  (3.1).  The main
equations of the RPE model are summarized in Table 3.1.
3.1.2 Bruch's membrane
BrM model includes only the ICL and OCL. Both are modeled as a homogeneous type I
collagen layer with proteoglycan ground substance. All the other layers are neglected.
This approximation is applicable as the collagenous layers form the bulk of BrM, and
the ICL forms the site of the highest fluid resistance  within BrM. Also, there is not
much data about the structure or properties of the basal laminae or EL. The model is
done in two scales: a smaller scale is used to describe the charged proteoglycan matrix
and a larger one to describe the collagen fibril matrix. The difference between ICL and
OCL is the tightness of the fiber matrices and  layer  thickness. The basic idea of the
model is schematically presented in Figure 3.3.
Corneal  stroma corresponds to BrM in the model by Edwards & Prausnitz.  The
corneal stroma has one additional structural level: collagen lameallae, which are layers
of collagen fibrils oriented in the same direction, and usually perpendicular to the neigh-
boring layers. The theory used for both proteoglycan and collagen fibrils in the present
Table 3.1. A summary of the equations used in the RPE model.
Description Equation
Paracellular pathway permeability P para=( 1PLS + 1PTJ )
−1
(3.1)
Lateral space P para=
ϵLS D0 H sp(λLS )
τLS l LS
(2.12)
Tight junctions PTJ=( nTJsPTJs+ (nTJs−1)PTJss )
−1
(3.9)
Transcellular pathway permeability P trans=( 2Pmem+ 1Pcyt , eff )
−1
(3.1)
Cell membrane Pmem=P mem
0 10−mv V (3.10)
Cytoplasm and melanin binding Pcyt=
D cyt , eff
hRPE
, Dcyt , eff =
Dcyt
1+Ka
(2.7), (3.13)
Total RPE permeability PRPE=P para+P trans (3.1)
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model is based on the proteoglycan scale of the model by Edwards & Prausnitz,  as
fibers in both scales are assumed to be randomly oriented. The equations used by Ed-
wards & Prausnitz are Equations (2.18), (2.19), (2.23) and (2.24), and in addition they
used the  electrostatic  theory by Johnson & Deen (1996)  (Equations  from (2.27)  to
(2.36)). (Edwards & Prausnitz 1998.)
In both scales the fibers, proteoglycan and collagen, are approximated with cylin-
ders, ignoring the finer surface characteristics. In addition, both fiber matrices are ap-
proximated with randomly oriented fibers, which is accurate for the proteoglycan matrix
but less accurate for the collagen matrix. In a real BrM, the collagen fibrils are mostly
aligned randomly within the plane, but the matrix includes some more aligned fibril
bundles,  which  can  be  thought  to  create  a  more  ordered  micro-environment.
Stylianopoulos et al. (2010b) studied the effect of network orientation to diffusion with
stochastic model and found very little practical difference between different magnitudes
of fiber alignment.
Both scales are modeled using the fiber matrix model (Equations from (2.18) to
(2.36)). The parameters needed for the model are proteoglycan radius rPG and collagen
fibril radius rCF as well as the proteoglycan volume fraction φPG,i and collagen fibril vol-
ume fraction φCF,i, for both the ICL and OCL, denoted by the subscript i. Also, as proteo-
glycan scale includes the electrostatic interactions, the proteoglycan surface charge den-
sity qA,PG is needed. The two scale model enables the calculation of the separate effects
of  the  proteoglycan  and  collagen  matrices.  First,  the  effective  diffusion  coefficient
within the proteoglycan ground substance  DPG,i,eff is calculated as in Equation (2.8) by
determining the effects  of  hydrodynamic,  steric  and electrostatic  interactions  on the
molecule's free diffusion coefficient and partitioning between the barrier and the free so-
lution. While this is done, the presence of the collagen fibril is neglected.
Then, the same process is  done with the collagen matrix,  but replacing  D0 with
DPG,i,eff, and calculating the effective diffusion coefficient collagen matrix  DCF,i,eff. The
electrostatic  interactions  between the diffusing molecule and collagen fibrils  are  ig-
nored,  because  the  electrostatic  interactions  are  more significant with  small  fibers
Figure 3.3. The basic idea and the material parameters concerning each layer in the
BrM model.  The white circles represent the collagen fibrils and the texture between
them the proteoglycan ground substance (dICL: thickness of the ICL; dOCL: thickness of
the OCL;  φPG,ICL: volume fraction of the proteoglycans in the ICL, excluding collagen
fibrils; φCF,ICL: volume fraction of the collagen fibrils in the ICL; φPG,OCL: volume fraction
of the proteoglycans in the OCL, excluding collagen fibrils; φCF,OCL: volume fraction of
the collagen fibrils in the OCL).
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(Stylianopoulos 2010a). The values of DCF,i,eff are calculated both in the ICL and OCL,
and the separate values are shown with respective subscripts.
The permeability coefficients of both  the ICL and OCL are then calculated using
Equation (2.37), with the ICL and OCL thicknesses dICL and dOCL, respectively, and the
total BrM permeability using Equation (3.2). The equations used for BrM  model are
summarized in Table 3.2. The subscript m used in the fiber matrix model is replaced by
the respective matrix. 
3.1.3 Choriocapillaris endothelium
The  fenestrations  of  the  CE are  the  major  diffusion  pathways for  small  molecules
through the endothelium. The fenestrations, paracellular and transcellular pathways are
connected in parallel. Therefore, the one with the highest permeability dominates. Also,
the permeability of openings of this kind is many orders of magnitude higher than the
permeability of RPE. Due to these reasons the CE model is simplified by ignoring the
paracellular and transcellular pathways. The present endothelium model is not based on
the model by Edwards & Prausnitz, as corneal endothelium lacks fenestrations.
The fenestrations are modeled with the diaphragms, which span over the fenstration
leaving triangular holes between fibers. The triangular holes are modeled with circular
holes which fit inside the sectors seen in Figure 2.4. Because of the circular pores, the
fenestrations  can be modeled  using the pore model.  The parameters needed for  the
model are diaphragm pore radius  rdia (m), fenestration height  hfen (m) and relative sur-
face area of the diaphragm pores ϵdia. The CE permeability coefficient is equal to fenes-
tration permeability, as it is the only diffusion pathway, and it is calculated as shown in
Equation (3.3).
Table 3.2. A summary of the equations used in the BrM model. The subscript i denotes
either ICL or OCL and the subscript m used in the fiber matrix model is replace by the
respective matrix.
Description Equation
Effective diffusion coefficient in PG scale D PG , i , eff=ΦPG , i , e D PG , i, i= ICLor OCL (2.8)
Diffusion coefficient D PG , i=D0 H PG , i S PG , i (2.19)
Partition coefficient ΦPG , i , e=∫
0
∞
g(h)exp[−E (h)]dh (2.27)
Effective diffusion coefficient in CF scale DCF , i , eff=ΦCF , i DCF , i (2.8)
Diffusion coefficient DCF , i=D PG , i , eff H CF , i S CF , i (2.19)
Partition coefficient ΦCF , i=exp[−ϕCF , i(1+ rsrCF )
2] (2.18)
Total BrM permeability P BrM=( d ICLDCF , ICL , eff +
d OCL
DCF , OCL ,eff )
−1
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3.1.4 Properties of the solute molecules
The diffusing solute molecules are approximated as spherical particles. Basically four
things are needed to predict the BRB permeability of a molecule: its size, free diffusion
coefficient, charge and lipophilicity.
Molecule's size and diffusion coefficient are linked together, as presented by Equa-
tions (2.3) and (2.4). The problem with these equations is that very rarely the radius or
the diffusion coefficient of drug molecules are known. Fortunately, the diffusion coeffi-
cient can be measured, so an empirical relationship between the molecular mass and dif-
fusion coefficient can be derived, as done by Avdeef (2010) at 37 °C as
D0=9.9×10
−5 M s
−0.453, (3.14)
where Ms is the molecular mass of the molecule (Da) and D0 has a unit of cm2 s−1. Equa-
tion (3.14) was fitted using 147 molecules with molecular mass between 30–1,200 Da
and with R2 = 0.94 (Avdeef 2010). Due to the size limitations of Equation (2.3), Equa-
tion (2.4) is used to calculate the radius of the molecules. The solute molecule charge qs
was  determined  using  Marvin  Calculator  Plugins  (MarvinSketch  5.10.1,  2012,
ChemAxon, http://www.chemaxon.com) by choosing the most common species at pH
7.4.  
The lipophilicity values are calculated using  Marvin Calculator Plugins. Both, the
partition coefficient (log KP) and distribution coefficient in pH 7.4 (log KD), are calcu-
lated.
To model the binding to melanin, the binding association constants (Ka) are needed.
Kadam  &  Kompella  (2010)  measured  the  affinities  of  eight  β-blockers  to  natural
melanin, but found only correlation of R2 = 0.10 with lipophilicity. The present model of
the melanin binding is very simplified, and it is important to get the right magnitude for
the association constants. Due to this reason, the values by Kadam & Kompella (2010)
are used to fit the association constants with lipophilicity, as their range of eight mole-
cules is quite large in comparison with other studies. When the fitting is done with the
log  KD values calculated using the Marvin Calculator Plugins, the resulting linear fit
with R2 = 0.25 is
K a=0.052 log K D+0.2268, (3.15)
where Ka has a unit of µM−1.
3.1.5 Parameters
This chapter presents the parameter values used in the BRB model. Parameters found in
literature or measured from images in literature are not discussed in detail, but are pre-
sented in Table 3.3 with the rest of the parameters. Parameters whose values are approx-
imated or calculated are presented in more detail in the text.
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Parameters for RPE
The parameters needed for  the RPE are the RPE cell and lateral space dimensions as
well as the parameters defining TJs.  As the TJ strands are formed by 10-nm particles
(Anderson & Van Itallie 2009), the strand height is taken as lTJs = 10 nm. Since it is dif-
ficult to measure the frequency or size of the strand breaks or the effect of the net-
work-like structure, an approximated value of ϵopen = 0.001 is used. This value is based
on the comparison between the measured and calculated permeabilities of hydrophilic
molecules. The TJ region half-width is approximated to be WTJ = 5 nm, based on the 10-
nm particle structure. The strand number is taken as nTJs = 5 (Rahner et al. 2004). The TJ
region height was measured by Rahner et al. (2004) to be hTJ = 0.30 µm. The TJ strand
separation is calculated by subtracting the TJ strands from hTJ and dividing it to equally
sized parts, thus resulting in dTJss = 65 nm.
The TJ pore radius measured by Van Itallie et al. (2008) was determined by calculat-
ing the hydrodynamic radius of the PEG oligomer that barely made it through the small
pores. The molecular mass of the oligomer with the radius of 0.4 nm is 323.80 Da (Van
Itallie et al. 2008). The radius of that oligomer and that of the TJ pores – comparable to
the molecules in this model – can be determined by using Equations (2.4) and (3.14) to
be rTJp = 0.68 nm. The pore separation is approximated to be dTJp = 10 nm, based on the
10-nm particle size (Anderson & Van Itallie 2009).
Parameter for BrM
The parameters needed for the modeling of the BrM are the ICL and OCL thicknesses,
the radii and fiber volume fractions of the proteoglycan and collagen fibrils in both the
ICL and OCL as well as the proteoglycan surface charge density. The ICL and OCL
thicknesses are taken as dICL = 2 µm and dOCL = 1.5, calculated by roughly dividing the
EL thickness equally and adding it to the real ICL and OCL thicknesses. This way, the
total BrM thickness is taken into account, while still excluding EL. The proteoglycans
are approximated only by the GAGs, neglecting the core proteins. Thus the proteogly-
can radius is equal to the GAG radius.
There are no data about the fiber volume fraction in the literature, so they have to be
approximated. The collagen volume fraction in the corneal stroma can be calculated
from the hexagonal arrangement of the fibrils to be around 0.25, based on values given
by Edwards & Prausnitz (1998). Based on the differences in images from the corneal
stroma and BrM (Goldbaum & Madden 1982; Hirsch et  al.  2001) and the fact that
corneal stroma is transparent and much thicker than BrM, the values for the BrM are es-
timated higher.  For  collagen  in  the ICL and  OCL,  the  values  of  φCF,ICL = 0.6  and
φCF,OCL = 0.3 are  approximated. As for the proteoglycan volume fractions, the approxi-
mated values are φPG,ICL = 0.25 and φPG,OCL = 0.08. It is important to note that φPG,ICL and
φPG,OCL are the volume fractions when collagen fibrils are ignored, as they only describe
the proteoglycan ground substance. These values correspond to volume fractions of 0.10
and 0.05 when including collagen fibrils, respectively.
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Parameters for CE
Only a few parameters are needed for the CE: the fenestration height, diaphragm pore
size and relative surface are of the diaphragm pores. The fenestrations are usually di-
vided into eight segments by the diaphragm as shown in Figure 2.4. The diaphragm pore
radius is calculated by using the sector angle of 45 degrees and sector radius of 12 nm
(Melamed et al. 1980). The resulting diaphragm pore radius is rdia = 3.3 nm.
The relative surface area of the diaphragm pores is determined as a product of the
relative surface area of the fenestrated region in the endothelium, the fenestrations in a
fenestrated region and the diaphragm pores in a fenestration. According to the investiga-
tion of Federman (1982) the choriocapillaris side facing the BrM has relative fenestrated
area of 0.6 around the macular region. The surface area of the fenestrations inside the
regions  is  calculated  from rabbit  endothelial  cell  membrane  freeze-fractured  figures
(Melamed et al. 1980), and the resulting value is 0.25. The relative are of the diaphragm
pores in a fenestration is calculated by assuming the fenestration radius of 40 nm, giving
a resulting value of 0.05. The relative surface area of the diaphragm pores in the CE is
ϵdia = 0.0075. All the parameters of the BRB model are given in Table 3.3.
3.1.6 Calculations
The calculations to study the functionality of the BRB model are separated into four
parts: 1) a comparison between the different methods of determining the solute radius,
2) a parameter behavior analysis to study the effects of molecular properties, 3) a com-
parison between the actual measured and predicted values to validate the model and 4) a
sensitivity analysis of certain model parameters to study their importance in the model.
All the calculations in the BRB model are done with Mathworks MATLAB software.
Melanin binding causes one problem to the model: the steady-state nature of the
model cannot take into account the accumulation of the drug molecules to melanin. To
model the accumulation, time and drug concentration would have to be included. Be-
cause  of  this,  the  BRB permeability is  modeled with  two modes:  with and without
melanin binding. The one with the binding represents the initial phase of the permeation
when there is no drug bound to the melanin. The latter mode represents the later phase
of the permeation, when the melanin is full of drug and can no longer bind any. These
two values set the limits for the real permeability coefficient. This two-mode method is
included in the parameter behavior analysis and validation.
Comparison between the molecular radii
The comparison between the solute radii is done by calculating the radii of ten mole-
cules used in this model with  different  methods. The molecules are chosen based on
their molecular masses. Equations (2.3) and (2.4) are used with the diffusion coefficient
calculated by Equation (3.14). The radii are compared to approximate the physical di-
mensions of the molecules, calculated with Marvin Calculator Plugins. The physical
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size is approximated as an average of the radii of the maximum and minimum projec-
tion area of the molecule.
In addition, the radii tabulated by Prausnitz & Noonan (1998) are also presented for
the molecules. They calculated the radii by determining the van der Waals volume of the
molecules and approximating them as spheres.
Parameter behavior analysis
The behavior of the BRB model is studied by varying lipophilicity, molecular radius and
charge. First, the behavior of paracellular and transcellular pathways in the RPE is stud-
ied alone. The value ranges used with the RPE for lipophilicity and radius are log KD =
–1...4 and  rs = 0.5...0.8 nm, respectively. Other values are kept constant in each case,
and values rs = 0.64 nm and log KD = 1.5.
BrM is studied by varying radius and charge with values rs = 0.5...0.8 nm and qs =
−1, 0 and 1, respectively. CE is studied with the same radius range as the RPE and BrM.
Table 3.3. The parameter values in the BRB model.
Description Parameter Value Reference
Parameters of RPE
RPE cell flat-to-flat distance dRPE 12 µm
Garron  1963,  Boulton  &  Day-
haw-Barker 2001
RPE cell height hRPE 12 µm Boulton & Dayhaw-Barker 2001
Lateral space half-width WLS 15 nm Ban & Rizzolo 2000
Lateral space tortuosity τLS 1.1 Garron 1963
TJ strand height hTJs 10 nm Anderson & Van Itallie (2009)
Open part size ϵopen 0.001 See text
TJ region half-width WTJ 5 nm See text
Strand separation dTJss 65 nm See text
TJ strand number nTJs 5 Rahner et al. (2004)
TJ pore radius rTJp 0.68 nm See text
TJ pores separation dTJp 10 nm Anderson & Van Itallie (2009)
Parameters of BrM
ICL thickness dICL 2 µm See text
OCL thickness dOCL 1.5 µm See text
Proteoglycan radius rPG 0.5 nm Ogston et al. 1973
Proteoglycan surface charge density qPG −0.10 C m−2 Mattern et al. 2008
Collagen fiber radius rCF 30 nm Booij et al. 2010
Proteoglycan volume fraction in ICL φPG,ICL 0.25 See text
Proteoglycan volume fraction in OCL φPG,OCL 0.08 See text
Collagen fibril volume fraction in ICL φCF,ICL 0.60 See text
Collagen fibril volume fraction in OCL φCF,OCL 0.30 See text
Parapameters of CE
Fenestration height hfen 50 nm Hogan & Alvarado 1967
Diaphragm pore radius rdia 3.3 nm See text
Relative surface area of the diaphragm
pores ϵdia 0.0075 See text
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Finally, the behavior of the whole BRB is studied together by changing lipophilicity and
radius with the same value ranges.
Validation with the measured values
The model validation is done by using measured permeability coefficients from several
studies for comparison with the calculated results. The solutes used for this model are
for many species and BRB parts. These include Bovine choroid and BRB (Ch-BRB)
(Steuer et al. 2004; Pitkänen et al. 2004; Kadam et al. 2011), bovine choroid and BrM
(Ch-BrM) (Cheruvu & Kompella 2006), porcine Ch-BRB (Kadam et al. 2011), porcine
Ch-BrM (Pescina  et  al.  2012),  human  Ch-BRB (Kadam et  al.  2011),  human  BRB
(Sanders et al. 2011), human RPE (Rajasekaran et al. 2003) and human Ch-BrM (Hus-
sain et al. 2002).
The solutes used in the validation and their properties as well as measured perme-
ability coefficients are presented in Appendix 1 Tables A1.1 and A1.1,  respectively. If
the permeability is measured in both apical-to-basal and basal-to-apical directions, the
smaller is used, as the other might include some forms of active transport. In addition,
in Pescina et al. (2012) the permeabilities were measured with multiple concentrations,
producing different values. In this case, the largest values are used, as melanin binding
has greater effect on smaller concentrations.
Sensitivity analysis
The sensitivity analysis  is  done by increasing and decreasing the values  of specific
model parameters and finding how much the change affects the permeability.  The pa-
rameters as chosen based on their uncertainty. The parameters chosen for the RPE are
the lateral space half-width (WLS), open part size (ϵopen), TJ region half-width (WTJ), TJ
pore radius (rTJp) and TJ pore separation (dTJp). The main focus in RPE is the paracellular
pathway and the novelty of the TJ model. The parameters of transcellular pathway were
already studied by Edwards & Prausnitz (2001). For BrM, the parameters are the pro-
teoglycan surface charge density (qPG) and proteoglycan and collagen fibril volume frac-
tions in both ICL and OCL (φPG,ICL, φCF,ICL, φPG,OCL and φCF,OCL). Due to the simplicity of
the CE model, it is left out of the sensitivity analysis.
Each parameter value is increased and decreased by 25 %. The simulations are done
with generic molecules. As there are no lipophilicity-dependent parts discussed here,
only the molecular radius and charge vary between molecules. For the RPE, two mole-
cules with the radii of rs = 5 and 7 Å are used. For BrM, four molecules of two sizes and
charges are used. The radii are rs = 5 and 7 Å and charges qs = −1 and 1. The lipophilic-
ity is kept constant at log KD = 1.5. The change in permeability is considered significant
when it is larger than 20 %.
47
3.2 Model of the half-perfusion chamber (chamber model)
This model is a FEM model of half-perfusion chamber concept with a stationary fluid
on one side of the BRB membrane and perfusion on the other side. The model is used to
study the effect of certain dimensions and other system parameters on the functionality
of the system. As a general concept, the geometry of the system is presented in Figure
3.4A. The upper part of the system is the donor chamber where the test molecules are
placed. The bottom part is the perfusion channel. One end of the channel is inlet and the
other is outlet, which leads to the acceptor chamber, where the samples are taken from.
To function properly, the system should affect the  BRB permeability measurement as
little as possible and the concentration in the acceptor chamber should be measurable.
The model was done using COMSOL Multiphysics software and all the additional
calculations were done with Mathworks MATLAB. First,  the geometry,  physics and
boundary conditions of the model are described. Following that, the different simulation
series are introduced.
3.2.1 Geometry
The large upper cylindrical part is the donor chamber to where the test molecules are
placed. It has a radius of 4 mm and height of 10 mm, so the volume is approximately
500 µl. Below the donor chamber is the vertical channel where the BRB is placed, de-
noted here as the BRB channel. This channel has a radius of 1 mm. This channel is di-
vided into two parts by the BRB. The  length of the upper part between BRB and the
Figure 3.4. The geometry of the chamber model. A: The parts of the chamber. B: A de-
tailed view of the BRB channel and the studied parameters (m fr: flow rate; ddcBRB: cham-
ber-BRB distance; dBRBpc: BRB-channel distance; hpc: channel height). C: The layout of
the channel from the top.
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donor chamber is  ddcBRB (m) and the part between BRB and the perfusion channel is
dBRBpc (m). The BRB channel is presented in detail in Figure 3.4B.
Below the BRB channel and perpendicular to it, is the perfusion channel. Its shape is
presented in Figure 3.4C. The channel has the height of hpc (m). The circular part in the
middle of the perfusion channel has the same radius as the BRB channel. The parts lead-
ing away from the middle are the inlet and outlet channels. The width of the channels at
the ends is 0.6 mm. The sides of the channel do not continue directly to the sides of the
circular BRB channel, because this would create very small elements on the upper sur-
face of the channel near the sides of the BRB channel. This problem is avoided by creat-
ing the little cuts shown in Figure 3.4C.
Different parts of the geometry are meshed with different accuracies. Because the
used dimensions vary and smaller dimensions need more elements, the accuracy of the
mesh is set according to the needs of each part of the model. The mesh of the donor
chamber is the least accurate, as it is only used to monitor the changes in drug concen-
tration in it. The rest of the model is meshed more accurately, as there is combined fluid
flow and diffusion. The smallest elements are found in the perfusion channel, as it has
the smallest dimensions in the system.
3.2.2 Physics and boundary conditions
The model uses two COMSOL physics: Laminar Flow in Computational Fluid Dynam-
ics module for the perfusion and Transport of Diluted Species in Chemical Reaction En-
gineering module for the diffusion. Each  of these physics has its own equations and
boundary conditions (BCs). Laminar Flow is modeled as stationary, because only the
velocity field of constant flow is needed. Transport of Diluted Species is modeled as
time-dependent, as the main interest is the diffusional behavior over time.
The governing differential equations in the Laminar Flow are Navier-Stokes equa-
tions and are given as
ρ(u⋅∇)u=∇⋅[−p I+η (∇ u+(∇ u)T )−23η (∇⋅u) I ], (3.16)
with
∇⋅(ρu)=0, (3.17)
where ρ is the fluid density (kg m−3), u is the fluid velocity field (m s−1), p is the pres-
sure (Pa), I is unit matrix, η is the dynamic viscosity (Pa s), T is temperature (K). BC in
the outer boundaries is a no slip wall, except for the inlet and outlet channels. The inlet
has a flow inlet BC, with a flow rate of mfr (µl min−1). The outlet BC allows free flow
out of the system. The only inner BC is the interior wall for the boundary representing
BRB, which restricts the fluid movements to the lower part of the system. The material
used for the fluid is water.
Transport of Diluted Species is governed by Fick's second law, including convective
part:
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∂c
∂ t
+u⋅∇ c=∇⋅(D ∇ c), (3.18),
where u is the velocity field. All the outer boundaries have no flux BC, except for the
outlet channel, for which the BC is outflow allowing the solute movement out of the
system. Again, the only inner boundary having BC is the one representing the BRB. The
BC for it is a thin diffusion barrier, which needs a permeability coefficient  PBRB,c. The
initial concentrations for the parts below and above the BRB are 0 and cdc (µg ml−1), re-
spectively. Concentrations with the unit of µg ml−1 have to be converted into mol in the
equations used. The free diffusion coefficient was chosen as Dc = 0.75×10−9 m2 s−1, cor-
responding to the average of the free diffusion coefficient of the drug molecules used in
the BRB model. The temperature used in both models is 37 °C.
Four probes are used to measure concentrations and fluxes in the system as func-
tions of time. Two domain probes are used to monitor the concentrations: one in the
whole donor chamber and second in the upper part of the BRB channel. Two boundary
probes are used to measure the total flux magnitudes across the BRB boundary and out-
let boundary.
3.2.3 Simulations and calculations
The functionality of the chamber is studied in two parts. First, the errors caused by cer-
tain system parameters to the functionality of the system are studied. Then, the measura-
bility of the concentration in the acceptor chamber is calculated by varying donor cham-
ber concentration as well as channel flow rate, and the results are compared to sensitiv-
ity of the analysis techniques.
Parameter-based errors in permeability
In the first part, the effects of the chamber-BRB distance ddcBRB, BRB-channel distance
dBRBpc, channel height  hpc, flow rate  mfr and permeability coefficient  PBRB,c to the mea-
surement errors caused by the system are simulated. The simulations series are done by
changing one or more parameters while keeping the others constant to show how each
affects the system. The BRB permeability values are changed within every simulation
series, and three values are used to represent different molecules and membranes. The
values used for the permeability coefficient in each simulation series are PBRB,c = 1×10−6,
1×10−5 and 1×10−4 cm s−1. The values of the parameters kept constant are given in Table
3.4. 
In the first simulation series, the chamber-BRB distance is simulated with values
dcdBRB = 0.5, 1, 2, 3, 4 and 5 mm, each with the three different permeability coefficients.
In the second simulation, the mutual effect of both the BRB-channel distance and perfu-
sion channel height is studied. The used values are dBRBpc = 0.5, 1, 2, 3, 4 and 5 mm, and
hpc = 0.15, 0.25, 0.5, 0.75 and 1 mm, resulting in 30 simulations per permeability coeffi-
cient. To ignore the effects of changes in flow rate due to the channel height changes,
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the flow velocity, instead of the flow rate, is kept constant between the simulations. In
the third simulation series the flow rate is varied using values mfr = 0.1, 0.5, 1, 5 and 10
µl min−1. The simulation time is taken as 6 hours, which shows the diffusional behavior
in long experiments and corresponds to the time used by Kadam et al. (2011). The error
simulations are summarized in Table 3.5.
The results from the boundary probes in COMSOL are fluxes with a unit of mol m−2
s−1. The idea is to determine the permeability coefficient (m s−1) in similar fashion than
in the experimental measurements. Basically this means that the fluxes have to be con-
verted to show the cumulative amount of substance that has passed the boundary probe.
The cumulative amount of substance as a function of time is calculated by Equation
 M (t)=A probe∫
t
J probe, (3.19)
where M is the cumulative amount of substance (mol) and Aprobe is the area of the respec-
tive probe boundary (m2). The permeability coefficient is then calculated using Equation
P= 1
ABRB c̄
dM (t)
dt , (3.20)
where ABRB is the BRB area in both cases and c̄ is the mean concentration (Kadam et al.
Table 3.5. The simulation series of the chamber model. Each simulation is done with the
three different permeability coefficient. The total number of simulation is 132.
Simulated parameter(s) Values Number ofsimulations
Parameter-based errors in permeability
Chamber-BRB distance ddcBRB = 0.5, 1, 2, 3, 4, 5 mm 18
BRB-channel  distance  and  channel
height
dBRBpc = 0.5, 1, 2, 3, 4, 5 mm and
hpc = 0.15, 0.25, 0.5, 0.75, 1 mm 
90
Flow rate mfr = 0.1, 0.5, 1, 5, 10 µl min−1 15
Measurability of donor chamber concentration
Flow rate mfr = 0.1, 0.5, 1, 5, 10 µl min−1 -
Donor chamber concentration cdc = 0.01, 0.1, 1 µg ml−1 9
Table  3.4. The  values  of  the  parameters  kept  constants  during  different  FEM
simulations. 
Description Parameter Value
Chamber-BRB distance ddcBRB 2 mm
BRB-channel distance dBRBpc 2 mm
Channel height hpc 0.25 mm
Flow rate mfr 1 µl min−1
Donor chamber concentration cdc 0.1 µg ml−1
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2011). The derivative is determined as the slope of the linear section of the curve, even
though the curves are non-linear in some cases.
For each simulation, two values are produced: the simulated permeability coefficient
based on the flux over  the BRB (P*BRB,c) and simulated permeability coefficient based
on the flux through the outlet,  (P*out,c). P*BRB,c describes the system's ability to achieve
the actual permeability of the BRB and P*out,c the system's ability to measure the actual
BRB permeability. When calculating P*BRB,c, the mean concentration is taken from the
probe that monitors upper part of the BRB channel to define more accurate value for
P*BRB,c. The total donor chamber mean concentration is used for P*out,c, as it is the con-
centration  that  is  experimentally  measurable.  P*BRB,c and  P*out,c could  be  calculated
straight from the fluxes, as with the present method the fluxes are consecutively inte-
grated and derived. However, using Equation (3.20) to determine the permeability coef-
ficients resembles more accurately the method used in the experimental measurements.
The results are presented as errors caused by the system to both permeability coeffi-
cients.  The BRB error percentage is calculated as (1 – P*BRB,c/PBRB,c)×100 % and outlet
error percentage as (1 – P*out,c/PBRB,c)×100 %.
Measurability of acceptor chamber concentration
The measurability of the concentration in the acceptor chamber is studied by varying
flow rate mfr and donor chamber concentration cdc. For cdc, the simulations are done with
the values cdc = 0.01, 0.1 and 1 µ ml−1. The values of other system parameters used are
those in Table 3.4. The three BRB permeability coefficients are also used with cdc. The
acceptor chamber concentration at time t can be calculated by Equation
cac (t)=
M (t)
m fr t
. (3.21)
The concentration at 3 hour time point is calculated and compared with sensitivity of the
analysis techniques. Concentration limit for the sensitivity is taken as 0.1 ng ml−1 (Jylhä
2013). The concentration after 3 hours represents well the magnitude of the concentra-
tion with those parameters. The measurability simulations are summarized in Table 3.5.
Total number of all the simulations is 132.
52
4 RESULTS
The results chapter is divided into two sections. In the first section, the results of the
four parts of the BRB model functionality studies are presented, followed by the results
of the chamber model simulations in the second section.
4.1 BRB model
The functionality of the BRB model was studied in four parts: 1) a comparison between
the solute radius, 2) a parameter behavior analysis, 3) a validation with measured data
and 4) a parameter sensitivity analysis.
4.1.1 Comparison between the solute radii
The comparison was done between Stokes-Einstein radius rSE (Equation (2.3)), Suther-
land radius rSu (Equation (2.4)), van der Waals radius and average projection radius, cor-
responding to the real molecular size. The molecules and different solute radii are pre-
sented  in  Figure  4.1.  The radii  calculated  with  Equation  (2.4)  are  generally a  little
higher than the average projection radius, but on average the magnitude is of similar
Figure 4.1. Radii of 10 molecules calculated by four different methods: Stokes-Einstein
radius (Equation (2.3)); Sutherland radius (Equation (2.4)), Van der Waals radius, a:
Prausnitz & Noonan 1998; Average projection radius, b: Marvin Calculator Plugin.
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scale. Both Equation (2.3) and van der Waals produce consistently smaller values than
the average projection radius.
4.1.2 Parameter behavior analysis
The parameter behavior analysis was done by calculating the effects of solute properties
on the RPE, BrM, CE and total BRB permeabilities. In addition, with RPE the paracel-
lular and transcellular permeabilities were also calculated. The studied solute properties
were radius, lipophilicity and charge.
RPE, paracellular and transcellular permeabilities
The behavior of the total RPE, transcellular and paracellular permeabilities as functions
of lipophilicity and solute radius are presented in Figures 4.2A and 4.2B, respectively.
Lipophilicity has no effect in paracellular pathway, which can be clearly seen in Figure
4.2A. Transcellular pathway permeability increases with increasing lipophilicity, but af-
ter log KD = 1 the effect of melanin binding is clearly seen. Without melanin, the perme-
ability increases logarithmically and around log KD = 3, the transcellular pathway be-
comes more permeable than the paracellular pathway. The total RPE permeability with-
out melanin is defined by paracellular pathway when log KD < 3 and by transcellular
pathway when log KD > 3. With melanin, the paracellular pathway totally defines the
RPE permeability.
The paracellular pathway depends only on the solute radius, but the dependence is
quite weak compared to the transcellular permeability as seen in Figure 4.2B. The para-
cellular permeability decreases with increasing solute radius. Without melanin, the tran-
scellular permeability becomes more significant than the paracellular permeability when
Figure 4.2: The behaviors of the total RPE, transcellular and paracellular permeabili-
ties as functions of solute lipophilicity (log KD) (A) and radius (rs) (B) with and without
melanin. RPE within melanin can be seen under the paracellular curves.
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rs > 5.6 Å. With melanin, the transcellular permeability is always at least three orders of
magnitude  smaller  than  the  paracellular  permeability.  With  rs >  7,  the  existence  of
melanin has no effect on the transcellular permeability. Without melanin, the total RPE
permeability is defined by the transcellular pathway with small radii and by the paracel-
lular pathway with rs > 5.6 Å. With melanin, the paracellular pathway again totally de-
fines the RPE permeability.
BrM and CE permeabilities
The behaviors of the BrM and CE permeabilities with increasing solute radius are pre-
sented in Figures 4.3A and 4.3B, respectively. The BrM permeability is also calculated
with three different solute charges. Generally, the BrM permeability decreases logarith-
mically with increasing solute radius. Positive charge speeds up and negative charge re-
tards the diffusion rate within the BrM matrix. The differences between charges begin to
vanish with high solute radii.  The  CE permeability also decreases logarithmically as
solute radius increases. However, the CE permeability is at minimum around 2 orders of
magnitude higher than that of BrM.
Total BRB permeability
The total BRB permeability, with and without melanin and as a function of lipophilicity
and solute radius is shown in Figures 4.4A and 4.4B, respectively. In addition, the RPE
(with and without melanin) and BrM permeabilities are presented. CE is ignored due to
the high magnitude difference. In relation to lipophilicity, RPE with melanin is the lim-
iting factor and defines the total BRB permeability. With melanin, the permeability is
constant regardless of lipophilicity. Without melanin, the RPE permeability begins to in-
crease rapidly at log KD = 2 and surpasses the BrM permeability near log KD = 4. So
Figure  4.3: The behaviors of the BrM permeability as a function of solute radius (rs)
and charge (qs) (A) and CE permeability as a functions of solute radius (rs) (B).  
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with highly lipophilic molecules and without melanin, BrM defines the BRB permeabil-
ity.
In relation to solute radius, the BrM permeability is higher within the calculated
range than the RPE permeability, with and without melanin. The effect of melanin bind-
ing can be seen with  rs < 6 Å as the BRB permeability without melanin begins to in-
crease more rapidly than the BRB permeability with melanin. Also, around  rs = 6.8 Å
there is a clear discontinuity in both cases of the BRB permeability.
4.1.3 Validation with the measured data
The validity of the BRB model was tested by comparing the calculated values to experi-
mentally  measured  values.  Figure  4.5A compares  the  measured  permeability  coeffi-
cients from bovine and porcine choroid-BRB (Ch-BRB) and human Ch-BRB, BRB and
RPE with the calculated permeability coefficients from the BRB model with and with-
out melanin. Most of the calculated values are within one order of magnitude from the
measured values, presented by the dashed lines. The calculated values are mainly con-
centrated between values 1 and 10×10−6 cm s−1, but measured values are more spread
out through the whole range. The differences between values with and without melanin
are small. There is a clear difference only between  three molecules between the two
cases:  clonidine, fluorescein, Rhodamine 123. Also, there are no clear differences be-
tween animal species.
For the BrM, the comparison is presented in Figure 4.5B, and all the measured val-
ues are from the Ch-BrM. At higher permeabilities, the calculated and measured values
are in similar scale, around 10−100×10−6 cm s−1. The calculated permeability does not
decrease with decreasing measured permeability, leading to differences of over two or-
ders of magnitude. The interspecies differences are clear, as for porcine and human all
Figure 4.4: The behaviors of total BRB, RPE and BrM permeabilities as functions of
solute lipophilicity (log KD) (A) and radius (rs) (B) with and within melanin.
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the values are within one order of magnitude and for bovine the difference is generally
greater. All the calculated permeabilities for the test molecules in the RPE, BrM, CE and
BrM can be seen in Appendix 2 Table A2.1.
4.1.4 Sensitivity analysis
In the sensitivity analysis, the significance of specific model parameters was studied by
varying their values by ±25 % and calculating the change in permeability of the respec-
tive BRB component. Figure  4.6 shows the effect  of the RPE parameters to  the  RPE
permeability. Only the magnitude of the change is shown. The chosen parameters were
lateral space half-width (WLS), open part size (ϵopen), TJ region half-width (WTJ), TJ pores
radius (rTJp) and TJ pore separation (dTJp). The changes were calculated for two solute
sizes. The effect of WLS is insignificant, as all the changes are under 3 %. The effect is
slightly higher with larger solutes and when the parameter value is decreased. With ϵopen
and WTJ the effect is more pronounced with the larger solutes, as both changes in param-
eter value lead to a change of just under 25 % and over 30 %, respectively. Parameters
ϵopen and  WLS do  not  have  any significant  effect  on  the  permeability  of  the  smaller
solutes. The effect of rTJp is very significant, as increasing its value by 25 % leads to al-
most 120 % increase in the large solute permeability. The decrease has no effect in the
Figure 4.5: A: A comparison between the measured and calculated permeability coeffi-
cients from Ch-BRB from bovine or porcine as well as multiple human tissues. B: A
comparison between measured and calculated permeability coefficient from bovine, hu-
man and porcine Ch-BrM. Human tissues include Ch-BRB, BRB and RPE.
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large solute permeability. Also, for small solutes it is the most significant parameter as
both decrease and increase lead to changes of 3−4 %. With large solutes, dTJp has no ef-
fect at all, and with small solutes the effect is small.
The parameters chosen for BrM are the proteoglycan surface charge density (qPG) as
well  as proteoglycan and collagen fibril  volume fractions in both  the  ICL and OCL
(φPG,ICL, φCF,ICL, φPG,OCL and φCF,OCL). The results are shown in Figure 4.7. The analysis is
Figure 4.6: The sensitivity of five RPE parameters: lateral space half-width (WLS), open
part size (ϵopen), TJ region half-width (WTJ), TJ pores radius (rTJp) and TJ pore separa-
tion (dTJp). The values were increased and decreased by 25 % and the change in the
RPE permeability of two molecules with different radius (rs) was calculated. Only the
magnitude of the change is shown.  
Figure 4.7: The sensitivity of five BrM parameter: proteoglycan surface charge density
(qPG) as well as proteoglycan and collagen fibril volume fractions in both ICL and OCL
(φPG,ICL, φCF,ICL, φPG,OCL and φCF,OCL). The values were increased and decreased by 25 %
and the change in the BrM permeability of four molecules with different radius (rs) and
charge (qs) was calculated. Only the magnitude of the change is shown.
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done for four solutes with different radii and charges. The effect of qPG is quite small for
all the four solutes. However, it is more significant for negatively charged solutes, as
their permeability changes by 8−9 %. With φPG,ICL and φCF,ICL, there is a clear difference
between decreasing and increasing the parameter value.  Both changes of φPG,ICL and
φCF,ICL by 25 % result in a change of 95−170 % and 50−65 % in the permeability, respec-
tively. The effect of φPG,ICL is more prominent with larger and negatively charged solutes
in both directions. With φCF,,ICL the differences between solutes are small. The effects of
both φPG,OCL and φCF,OCL are nonexistent for all the solutes.
4.2 Chamber model
The functionality of the half-perfusion chamber concept was studied by varying the val-
ues of certain parameters and monitoring how the changes affect the system function.
After these simulations, the measurability of acceptor chamber concentration was stud-
ied.
4.2.1 Parameter-based errors in permeability
The errors caused by four parameters to the system function were tested by varying the
value of each of them while keeping the others constant. The four parameters were the
chamber-BRB distance (ddcBRB), BRB-channel distance (dBRBpc), channel height (hpc) and
perfusion  flow rate  (mfr).  In  addition,  the  effect  of  the  real  permeability  coefficient
(PBRB,c) was also simulated by using three different permeability values for each simula-
tion. The results were calculated as BRB and outlet errors, first of which describes the
systems ability to achieve the real permeability and latter the system's ability to measure
the real permeability. 
Effect of the chamber-BRB distance (ddcBRB)
The results for ddcBRB simulations are shown in Figure 4.8 for the three different values
of PBRB. Figure 4.8A presents the behavior of the BRB error. Increasing ddcBRB increases
the BRB error with all the values of PBRB,c. The increase in error is smaller with PBRB,c =
1×10−6
cm s−1, and in similar scale with the other two. Increasing PBRB,c increases the error con-
siderably, as seen from the three curves.
Figure 4.8B presents the behavior of the outlet error in the same cases. The outlet er-
rors behave similarly to the BRB errors, but are all slightly higher for each value of
PBRB,c. The difference between the  errors in Figures  4.8A and  4.8B is most prominent
when PBRB,c = 1×10−6 cm s−1.
Effects of the BRB-channel distance (dBRBpc) and channel height (hpc)
The  results  for  the  effects  of  dBRBpc and hpc on  the  BRB  and  outlet  errors  with
PBRB,c = 1×10−6 cm s−1 are shown in Figures 4.9A and 4.9B, respectively. In the case of
the BRB error, the behavior of the error with hpc = 0.15 mm is different from the others,
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decreasing at first and increasing after dBRBpc = 1 mm. The behavior of all the other val-
ues of  hpc is similar to each other, increasing as  dBRBpc increases and leveling out near
dBRBpc = 5 mm. Despite slightly different behavior of hpc = 0.15 mm, the differences be-
tween the channel heights are minimal. With the outlet error, the differences between
different values of hpc are more clearly seen compared with the BRB error. At low val-
ues of dBRBpc, the higher channels have lower error, but the differences vanish as dBRBpc
increases. Again, hpc = 0.15 mm differs most from the rest. The outlet errors of all the
channel heights begin to increase more rapidly after dBRBpc = 2−3 mm. Also, when com-
paring the BRB and outlet errors, the effects of dBRBpc and hpc  are more prominent with
the outlet error.
The  results  for  the  effects  of  dBRBpc and hpc on  the  BRB and  outlet  errors  with
PBRB,c = 1×10−5 cm s−1 are shown in Figures 4.9C and 4.9D, respectively. With the BRB
error,  the  differences  between  different  values  of  hpc are  minimal,  apart  from
hpc = 0.15 mm, which shows a slightly lower error than the rest. With all the values of
hpc, the error increases with increasing dBRBpc and levels out near dBRBpc = 5 mm. For the
outlet error, there is no clear trend with the different values of hpc, but they increase
quite linearly with the increasing  dBRBpc. The different behavior between the BRB and
outlet error is clear, as the outlet errors increase to higher values than the BRB errors.
The  results  for  the  effects  of  dBRBpc and hpc on  the  BRB and  outlet  errors  with
PBRB,c = 1×10−4 cm s−1 are shown in Figures 4.9E and 4.9F, respectively. With the BRB
error, the differences between values of hpc are again minimal, apart from hpc = 0.15 mm.
The errors of all the values of hpc increase with the increasing dBRBpc and level out near
dBRBpc = 5 mm. With the outlet error, the value of hpc has minimal effect on the error. All
the values of  hpc similarly increase with the increasing dBRBpc. The differences between
the BRB and outlet errors are small compared to two lower values of PBRB,c.
Figure  4.8: The effect of chamber-BRB distance (ddcBRB) to BRB(A) and outlet errors
(B), with the three different real permeability coefficients (PBRB).  
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When the errors and behaviors between different values of PBRB,c are compared with
each other as dBRBpc and hpc are changed, it is evident that the general error increases with
Figure  4.9: The effects of BRB-channel distance (dBRBpc) and channel height (hpc) to
BRB and outlet errors percentages, with PBRB = 1×10−6 cm s−1 (A and B), PBRB = 1×10−5
cm s−1 (C and D) and  PBRB = 1×10−4 cm s−1 (E and F).  Note the scale of the y-axes.
61
increasing PBRB,c, as already seen in Figure 4.8. Also, the differences between the behav-
iors of the BRB and outlet errors are clearer with the small values of PBRB,c.
Effect of the flow rate (mfr)
Figures 4.10A and 4.10B show the behavior of the BRB and outlet errors with the in-
creasing value of mfr, respectively. With all the values of PBRB,c, the BRB errors decrease
as mfr increases. The decrease is fastest when PBRB,c = 1×10−5 cm s−1. With the outlet er-
ror,  the  behavior  is  not  as  straightforward,  but  the  trend  is  clearly  the  same.  With
PBRB,c = 1×10−6 cm s−1, the error decreases until about mfr = 1 µl min−1, after which it be-
gins to increase and again decrease near mfr = 10 µl min−1. The differences between the
BRB and outlet errors are small, but more noticeable with the lower values of  PBRB,c.
Again it is clearly seen in both Figures  4.10A and  4.10B that the increasing  PBRB,c in-
creases both errors.
4.2.2 Measurability of acceptor chamber concentration
To study the measurability of the acceptor chamber concentration, the concentrations
with different flow rates (mfr), donor chamber concentrations (cdc) and BRB permeabil-
ity coefficients (PBRB,c) were calculated and compared to analysis technique sensitivity.
The results for acceptor concentration as a function of flow rate with the three BRB per-
meability coefficients are shown in Figure  4.11A. The sensitivity is presented by the
dotted line. The concentration is above the sensitivity with the two higher permeabilities
within  the  simulated  flow  rate  range.  However,  it  is  clearly  seen,  that  with
PBRB,c = 1×10−5 cm s−1 the concentrations will decline under the sensitivity when mfr > 10
µl min−1. For PBRB,c = 1×10−6  cm s−1, the acceptor concentration decreases below the sen-
sitivity when mfr = 1 µl min−1.
Figure 4.10: The effect of flow rate (mfr) to BRB (A) and outlet errors (B), with the three
real permeability coefficients (PBRB). Note the logarithmic x-axis.
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The results between acceptor and donor chamber concentrations with the three per-
meabilities are shown in Figure 4.11B. Again, with the two higher permeabilities the ac-
ceptor concentrations stay above the sensitivity. However, with  PBRB,c = 1×10−5 cm s−1,
the acceptor concentration declines below the sensitivity just at the lower limit of the
simulated donor concentration range. With PBRB,c = 1×10−6 cm s−1, the acceptor concen-
tration becomes unmeasurable as the donor concentration drops below cdc = 0.1 ng ml−1.
Figure 4.11: The effect of flow rate (mfr) (A) and donor chamber concentration (cdc) (B)
to the acceptor chamber concentration,  with the three real permeability coefficients
(PBRB). The sensitivity of the analysis technique is represented by the dashed line. Note
the logarithmic axes.
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5 DISCUSSION
In this thesis, two mathematical models related to BRB permeability and its measure-
ment system were constructed.  The main aim of the models is to  predict the  barrier
properties of the outer blood-retinal barrier (BRB) and the functionality of a permeabil-
ity measurement system. In the first model, the diffusion barrier formed by the BRB
was modeled. The aims of this BRB model were to construct and validate it as well as to
determine the importance of different parts of BRB to the barrier function. The second
model was of a half-perfusion chamber setup for the BRB barrier property studies. The
model was used to study the effects of certain system dimensions and other parameters
to the system's functionality.
5.1 BRB model
The BRB model presented in this thesis is the first model of its kind for BRB, base on
the literature review. There is a need for this kind of model to explain experimental re-
sults, as it can link the solute permeability to the state of the BRB, be it normal or dis-
eased (Ranta & Urtti 2006). It can be used to facilitate the experimental permeability
studies, as it enables the linking of permeability coefficient with the physicochemical
properties of the BRB. Thus, it may reveal why certain drugs have a certain permeabil-
ity coefficient. Basically, the model relates the molecular properties to the interactions
between the molecule and structures that form the BRB, and calculate how much they
hinder the diffusion rate.
The model includes a much more detailed description of  the  BRB than any of the
preceding pharmacokinetic models, such as those by Mac Gabhann et al. (2007), Amrite
et al. (2008) and Ranta et al. (2010). There are similar models for other biological barri-
ers,  though, like  for the cornea  (Edwards &  Prausnitz 1998; 2001) and  the  skin  (Mi-
tragotri 2003). This model uses mostly the same theory as those models for the other
barriers, but some components, such as the model of RPE TJs, are more accurate than in
any of the preceding ones. 
To enable the use of the BRB model in further studies, the functionality of the model
has to be evaluated. This is done in the following chapters, where first the results of the
calculations are discussed, followed by the discussion how different assumptions and
simplifications in the model may have affected the results. Finally,  the discussion is
summarized and future prospects of the model are considered.
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5.1.1 Assessment of the results
To evaluate the functionality of the model, four different analyses were conducted. First,
the different methods of determining the solute radius were compared. Then, the behav-
ior of the model in relation to solute radius, charge and lipophilicity was investigated,
followed by the model validation by comparing the calculated and measured permeabil-
ity values. Finally, a sensitivity analysis concerning specific model parameters was car-
ried out.
Comparison between the solute radii
The compared methods to calculate the solute radius  were Stokes-Einstein Equation
(2.3), Sutherland Equation (2.4) and van der Waals radii based on the solute volume.
The radii were compared with actual solute size approximated by molecule's average
projection radius. It is evident that Equation (2.4) is clearly a better method compared to
Equation (2.3),  as it  follows much more closely to the real molecular size. Equation
(2.3) produces consistently smaller radii and should not be used for small molecules, as
it underestimates the radius.
The accuracy of solute radius is important for several reasons. First of all, it affects
the permeabilities in different geometries. For example, if Equation (2.3) was used to
calculate the solute radius, the permeabilities from fiber matrix model would be much
higher with the same matrix parameters. Another important factor is the surface charge
density. With smaller radius the surface charge density increases compared to the larger
one.
Parameter behavior analysis
The permeability behavior of BRB and its parts in relation to solute lipophilicity and ra-
dius was studied. RPE was further divided into paracellular and transcellular pathways
and modeled with and without melanin binding. The RPE permeability is mainly gov-
erned by the paracellular pathway regardless of solute properties and especially with
melanin.  As the normal mode of permeation should be somewhere between the two
melanin modes, the real significance of transcellular pathway – and solute lipophilicity
– according to this model, is very small. Edwards & Prausnitz  (2001) also concluded
that this kind of transcellular pathway has  a  little effect in the epithelial scale. Their
model worked better as a whole, as they also included the pathway of diffusion within
the cell  membrane.  With increasing solute radius,  the paracellular permeability does
clearly decrease, but not nearly in the same extent as the transcellular permeability. The
discontinuity in paracellular permeability at rs = 8.9 Å, is caused by the TJ pore radius
(rTJp = 8.9 Å). This is quite similar behavior as seen in experimental measurements by
Van Itallie et al. (2008).
The behavior of the BrM permeability with increasing solute radius is very similar
in shape to the experimental measurements by Hussain et al. (2010) and Zauas-Santiago
et al. (2011).  The effect of negative molecular charge is intuitive, as objects with the
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same charge repel each other, which in turn retards the diffusion rate. However, the ac-
celerated diffusion of positively charged solutes may not be realistic as the proteogly-
cans bind these solutes in some extent,  which also slows down the diffusion. The CE
model is quite simple and the resulting behavior as a function of solute radius comes
straight from the pore model. There is no measured data to compare the CE permeabil-
ity behavior to. As the solute size is probably the only main factor affecting the perme-
ation in the real case, the model can be estimated to be fairly accurate.
When the components of the BRB are studied together, it is clear that the RPE con-
tributes most to the total permeability, especially with melanin. This aligns well with the
literature (Pitkänen et al. 2005; Kadam et al. 2011). BrM does form a significant perme-
ability barrier with highly lipophilic molecules. This behavior is quite similar to the one
produced by the cornea model by Edwards & Prausnitz (2001),  in which the corneal
stroma becomes the least permeable component with highly lipophilic molecules.
In the literature, there are contradicting results about the relationship between per-
meability and solute lipophilicity. Pitkänen et al. (2005) found that the BRB permeabil-
ity increases with increasing lipophilicity, and the finding of Kadam et al. (2011) were
contradictory. One possible reason for this difference in behavior might be that Kadam
et al. normalized their results with tissue thicknesses and melanin content. However, the
differences in permeability within each study was small. This might mean that actually
with lipophilic molecules, the enhanced cell membrane permeability is countered with
enhanced melanin binding, thus decreasing the impact of lipophilicity on the total per-
meability. In addition, the standard deviations calculated by Kadam et al. (2011) are sig-
nificantly smaller than those calculated by Pitkänen et al. (2005), which might indicate
to differences in calculation methods between the two studies.
The orders of magnitude between the permeabilities of different  BRB components
are large. In the model between the RPE and BrM, the difference is around 25-fold for
medium sized solutes. Pitkänen et al. (2005) concluded that this difference should be
around 70- to 170-fold for 4 kDa FITC-dextran. Of course,  FITC-dextrans are linear
molecules and much bigger than drug molecules, so this comparison might not be feasi-
ble. In the present model, the difference between the BrM and CE is around 40- to 190-
fold, depending on the solute radius. It is difficult to estimate the accuracy of this differ-
ence, as there is no data available from the CE.
As a summary, the RPE forms the most significant component in the BRB. Due to
its small significance  of the transcellular pathway.  As this is the only lipophilicity-de-
pendent part  of the model, lipophilicity has very little effect.  Thus, the whole BRB
model  depends  mainly on the  paracellular  pathway,  which further  depends only the
solute radius. This leads to a narrow value range of permeability values.
Validation with the measured data
The model was validated by comparing the calculated permeabilities with the measured
values. The calculated BRB permeability values are within a very narrow permeability
range regardless of the properties of the solute. The measured values vary within much
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larger range. The issues in the model behavior leading to the narrow range, such as the
transcellular pathway, were discussed in the preceding section. The differences between
species are not noticeable, which can be contributed to comparability of different exper-
imental studies.
The comparison for  just  the  BrM model shows better results  than the comparison
with the BRB model. Only few permeabilities differ more than one order of magnitude,
namely  the bovine  Ch-BrM.  Again  the values reside within small permeability range,
which indicates a flaw in the BrM model. Although the choroid ECM is more permeable
than BrM, its larger thickness does make significant part of the measured permeability
values. Because of this, the present BrM model probably underestimates the real BrM
permeability, as  do  the  measured  results.  In  addition,  the  choroid  contains  melanin
(Pescina et al. 2012), which in turn decreases the comparability.
There are some  complications concerning the comparability of  the calculated and
experimentally measured values. First of all, the number of the experimental studies is
low. Most of these studies use either bovine or porcine eyes,  but the present model is
based on the human BRB. Kadam et al. studied the permeabilities of choroid-RPE in the
eyes from multiple species, including human, and concluded that the differences be-
tween species are noticeable. Bovine and porcine are close to each other, but humans
have about 3-10 times higher permeabilities depending on the molecule. The differences
between species leveled out as the permeabilities were normalized with tissue thickness
and melanin content. (Kadam et al.  2011.) Secondly, there actually is  a lack of data
about the permeability of only the BRB. Although RPE forms the most significant bar-
rier in Ch-BRB and BrM in Ch-BrM system, choroid still does affect the permeability
due to its larger thickness.  The comparability between different experimental studies
may be a problem due to different study conditions and methods. These issues should be
taken into account when viewing the validation results. In addition, it is more important
to predict the magnitude and behavior of the permeability, not the exact absolute value,
which is difficult to measure experimentally due to the varying experimental conditions.
Sensitivity analysis
The importance of five parameters from both the RPE and BrM models was studied by
changing their value by 25 % to both directions and calculating the change in perme-
ability. Large effect in permeability caused by these changes indicates the importance of
the parameter. For RPE, the studied parameters were from the paracellular pathway, and
two different sizes of solutes were used. TJ open part size (ϵopen) has a significant effect
on the larger solutes which are unable to diffuse through the TJ pores. For small mole-
cules, ϵopen has a little effect as they mainly diffuse through the pores. The effect of the
TJ region half-width (WTJ) is noticeable with larger solutes,  as the slit affect more the
diffusion rate of large molecules. TJ pore radius (rTJp) is very important parameter. For
small solutes, the value change has only a small effect, but for large solutes the effect is
very significant. This is caused by the fact that the value of rTJp increases above the large
solute radius when increased by 25 %, which leads to considerable increase in perme-
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ability  (approximately 120 %).  Lateral space half-width (WLS) and  TJ pore separation
(dTJp) are both insignificant. As a summary, the most important parameters in the para-
cellular pathway are the TJ open part size, TJ region half-width and TJ pore radius.
For BrM, the studied parameter were the proteoglycan surface charge density (qPG)
as well as proteoglycan and collagen fibril volume fractions in both the ICL and OCL
(φPG,ICL, φCF,ICL, φPG,OCL and φCF,OCL).  The values of the volume fractions were estimated,
as there was no data  available. Four solutes with two different radii and charges were
used. Parameter φPG,ICL is the most important parameter studied in the BrM model, as the
change  in  its  value  leads  to  the largest  change  in  the  BrM permeability.  For  large
solutes, the effect is even more significant than for small ones, as it is more difficult for
them to diffuse through the fiber matrix. Although the changes caused by the variation
of  φCF,ICL are  also large,  they are similar  to all  the solutes.  The  differences  between
solutes with the changes of φPG,ICL arise from the fact that the radius of the proteoglycans
is in similar scale as that of the solutes. With φCF,ICL, the size difference is larger. Because
of the significance of φPG,ICL and φCF,ICL, the underestimation of  the  BrM permeability
discussed earlier is partly caused by too high values of these two volume fractions. The
effect of qPG, φPG,OCL and φCF,OCL are insignificant.
5.1.2 Model assumptions and simplifications
Many assumptions and simplifications of the BRB anatomy had to be made during the
model construction. Next, their justification and possible impact on the model function-
ality and the limitations of the model are discussed.
Assumptions and simplifications of the RPE model
It is quite clear that the transcellular pathway of  the  RPE model has many problems,
which stem from multiple reasons. The transcellular model, especially cell membrane
permeation, is different from the rest of the model. It calculates the permeability based
on fitted equation, whereas the other parts of the model use the free diffusion coefficient
and multiply it with different coefficients.  This means that there may be large differ-
ences between permeabilities. Of course, the cell membrane forms a quite different bar-
rier compared to the other parts of the model, as there are a lot of different interactions
between the membrane and solute  molecules.  Edwards & Prausnitz (2001) concluded
that their model tends to overestimate the cell membrane permeability by approximately
two  orders of magnitude.  One thing that might affect the transcellular permeability is
how van der Waals volume is calculated, as Edwards & Prausnitz (2001) used different
software for this.
The applicability of the diffusion pathway  within the cell membrane used by Ed-
wards & Prausnitz (2001) was tested in the present model, but it led to too high perme-
abilities,  and was thus ignored.  This partly balances out the overestimation in the cell
membrane permeability model concluded by Edwards & Prausnitz. The relationship be-
tween the cell membrane permeation and diffusion pathways within the cell membrane
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is  difficult.  In  the present  model,  lipophilic  molecules  readily permeate  through the
whole membrane. However, in reality a lipophilic molecule might not partition out of
the hydrocarbon core into the cytosol, as this is energetically more unfavorable environ-
ment. This would mean that the diffusion pathway within the cell membrane is signifi-
cant, but as mentioned, difficult to model.
In addition to the cell membrane permeability, the melanin binding has a huge effect
on the total transcellular permeability. The present model of melanin binding is very
simple, but it would have been difficult to model it more accurately in the scope of this
thesis. Melanin binding is a complex process influenced by many other things than just
lipophilicity, like the atom scale molecular properties (Lowrey et al. 1997).
In the present model, the effects of basal infoldings and apical microvilli in the RPE
and the increased cell membrane area were ignored.  They would not have made the
transcellular pathway more significant, as they would have only multiplied the transcel-
lular permeability with a small constant that describes the increased area. The effect of
active transport is one source of error when comparing predicted and experimentally
measured  permeabilities.  For  example  some  solutes,  such  as  carboxyfluorescein
(Kimura  et  al.  1996),  are  actively transported from apical  to  basal  direction,  which
might decrease the measured permeability in the other direction.
The paracellular pathway is modeled with a novel method compared to preceding
models. The TJ structure in the present model more accurately follows the real TJ struc-
ture than for instance the model by Edwards & Prausnitz (2001). The biggest simplifica-
tions are the omission of the web-like structure of the TJs and the TJ pore charge selec-
tivity, which would needlessly increase the complexity of the model. Also, both the slit
and pore models – with which the paracellular pathway model is based – assume that
the geometry is perfect and that there is no binding with the walls, which may be incor-
rect but difficult to model.
Assumptions and simplifications of the BrM model
With BrM, the most important simplification is the modeling of only the ICL and OCL.
For example, both basal laminae may be significant barriers, as one fourth of proteogly-
cans in BrM is primarily located in the RPE-BL (Inatani & Tanihara 2002). This would
probably form a barrier against diffusion, but also increase the number of parameters.
Due to the lack of data, the number of parameters estimated was kept at minimum. The
present model only takes into account the collagen fibrils and proteoglycans. In reality,
BrM  includes  many  other  biomolecules,  such  as  other  types  of  collagens  and  fi-
bronectin, with different properties. Also, with increasing age, lipids accumulate into
BrM, which would relate its permeability to solute's lipophilicity. However, it would be
difficult to model the other biomolecules or lipids with the models and equations uti-
lized in the present model.
The fiber matrix model itself has some simplifications. The fibers in the model are
randomly oriented, homogeneously distributed, immobile and rigid. In reality, the ECM
geometry is  not  this  strict.  The fibers can move about and there might  be inhomo-
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geneities in the fiber distribution, because of which the fiber matrix model tends to un-
derestimate the diffusion rate. (Phillips 2000.)
Another question is the applicability of the fiber matrix model to the BrM model. It
is derived for diffusion in hydrogels, whose volume fractions are mainly under 0.10
(Phillips 2000). The high volume fractions used in the present model are well  above
this. So, the correctness of the fiber matrix model at higher volume fractions is difficult
to estimate. For perfect square array of fibers, the diffusion is blocked when fibers touch
each other and the volume fraction can be calculated to be 0.79. The volume fraction for
random matrix that totally blocks diffusion is probably not so much different and using
values as high as used in the present model (0.60) might lead to incorrect results, due to
the limits of the fiber matrix model.
In  addition  to  the  hydrodynamic  and  steric  interactions  between  the  solute  and
fibers, also the accuracy of electrostatic interactions depends on the fiber volume frac-
tion. The model created by Johnson & Deen is most accurate when the interactions are
only between one particle and one fiber. (Johnson & Deen 1996.) The issue with this is
that the high fiber volume fraction might lead to more complex interactions between the
solute  and multiple  fibers.  The  unrealistic  behavior  of  attractive  electrostatic  forces
mentioned earlier is caused by the fact that the electrostatic solute-fiber model was de-
rived only for repulsive interactions (Stylianopoulos et al. 2010a).
Assumptions and simplifications of the CE model
With the CE model, the paracellular and transcellular pathways were ignored, and only
the diaphragmed fenestrations  were modeled.  The transcellular  pathway would have
been modeled similarly to the RPE model. In the paracellular pathway, the parameters
concerning the TJs would have been adapted to  the  CE. Nevertheless, these pathways
would have become very tight compared with the fenestrations, as can be seen from the
RPE model permeability results. As the magnitude of the CE model results seems cor-
rect, these simplifications seem justified.
Assumptions and simplifications of the solutes
The main simplification with the solutes was the spherical shape. Some molecules are
not spherical, so for example the orientation of a molecule trying to diffuse through a TJ
pore becomes significant. However,  slit, pore and fiber matrix models assume this ge-
ometry, and it would be impractical to take into account the individual shapes of each
molecule. Also, the molecular size is limited to under 1000 Da as it is calculated with
Sutherland equation.
The  solute  sizes  were  calculated  as  molecules  without  hydration.  With  charged
solutes,  water  molecules  attracted  by the  charge  form a  hydration  layer  around the
solute, which increases the molecular size (Hämäläinen et al. 1997) and makes diffusing
through pores and membranes energetically more unfavorable (Nelson 2008).
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The solute's charge was taken as the charge of the most common chemical species.
However, as practically with all the molecules, the most common species was around
99 % of all the molecules, this simplification has no impact on the model. There are
multiple databases including tabulated lipophilicity values. Some include measured val-
ues and some calculated values. The problem with most of the databases is that none of
them includes all the molecules needed for this model. Due to different study methods
and conditions, values from different studies vary. This makes combining data from dif-
ferent databases undesirable. Because of these reasons, all the lipophilicity values are
calculated using Marvin Calculator Plugins.
5.1.3 Summary and future prospects
The BRB model is the first model of its kind for BRB and it is more accurate than the
existing pharmacokinetic  models.  As already discussed,  there  are  some  areas of im-
provement with the model. The main issue in the BRB model is the lack of experimental
data. In spite of its problems, it is able to predict the right magnitude for the permeabili-
ties. However, the more accurate behavior based on the molecular properties is not seen.
The same theory with different parameter values could easily be extended for other
species, although it was constructed for the human BRB.
The model forms a good platform for the refinement of the different components. In
the future, there are several directions this model can be taken and application it can be
used for. One interesting direction is more dynamic behavior of the BRB. The BRB per-
meability can be regulated with different methods, for example by different claudins in
the TJs or with changes in active transport. The integration of these into the model could
enable the simulation of the dynamic behavior of the BRB in different scenarios, such
as AMD. The changes in solute permeability caused by AMD could be traced back to
the structural and behavioral changes caused by it. Additionally, by changing the system
parameters the model shows the effect on permeability, which can be compared to the
changes caused by AMD. Also,  one possible  direction is  to  try to  join together  the
molecular permeability studied in this model with the TER values across the BRB. This
kind of model would enable more complete description of the BRB barrier function.
The model can be used to design new drugs for AMD, as it is possible to predict the
permeability of a drug based on its properties. Other possible uses for the model are the
prediction and guidance of experimental in vitro drug analyses. In addition, the model
can be used to replace the constants describing permeability in the pharmacokinetic
models. This would enable much more accurate modeling and simulations of drug de-
livery from a periocular implant or blood circulation. In addition to the pharmacological
and pathological applications, the  BrM model can be utilized to study the diffusional
properties of polymer biomaterials for the replacement of BrM in RPE transplantation.
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5.2 Chamber model
The finite element method (FEM) model  was constructed and used to simulate the ef-
fects of different parameters to  the  functionality of a half-perfusion chamber  concept.
The idea is to study how certain system parameters affect the functionality of the system
and to find out what causes the possible measurement errors. This kind of models of ex-
perimental measurement tools are important, as they show where the errors in the sys-
tems come from. 
5.2.1 Assessment of the results
The functionality of the chamber was studied by varying the values of certain parame-
ters  and monitoring  how these changes  affect  the  system function.  First,  the  errors
caused by the parameters to the permeability measured from the system were simulated.
Following that, the measurability of the acceptor chamber concentration was studied.
Parameter-based errors in permeability
The effects of four parameters to the chamber-based measurement error were simulated.
The parameters were the chamber-BRB distance (ldcBRB), BRB-channel distance (lBRBpc),
channel height (hpc), perfusion flow rate (mfr) and BRB permeability coefficient (PBRB,c).
Two errors were considered: BRB error representing the system's ability to reach the
real BRB permeability and outlet error representing the system's ability to actually mea-
sure the real BRB permeability. The simulations were done by varying one or two of the
investigated parameters and keeping the others constant.  Three values of  PBRB,c were
used to study the chamber's ability to measure the permeability of different membranes.
First of all, the effect of the real permeability coefficient PBRB,c to both the BRB and
outlet errors is very significant regardless of all the other parameters. At least two rea-
sons can be considered for this remarkable dependence of both the BRB and outlet er-
rors on PBRB,c. The first reason is more important to the BRB error than to the outlet er-
ror. In the beginning of the measurement, the concentration gradient between the sides
of the membranes is at its maximum. When the measurement proceeds, the concentra-
tion above the BRB decreases and below the BRB increases, thus decreasing the gradi-
ent. However, Equation (3.20) uses the time average concentration above the BRB and
assumes zero concentration below the BRB. Because this assumption is never actually
true, there is a small error. This error can be seen as a BRB error and it is under 10 %.
The second reason for the increasing error with increasing value of  PBRB,c is diffusion
rate. As an example, if the permeability of water-filled channel with the length of 2 mm
is calculated with equation (2.7), the result is 3.75×10−5 cm s−1. This value is in similar
scale with the higher values of  PBRB,c. If this channel is connected in series with  the
BRB, its importance increases with increasing  PBRB,c. Because of this, the system can
never measure the actual value of PBRB,c. Even if both ldcBRB and lBRBpc are zero, the diffu-
sion rate within the donor chamber limits the flux across the BRB.
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Basically the value of PBRB,c sets the base level for both the BRB and the outlet er-
rors, but the more precise changes are caused by the changes in the parameters of cham-
ber geometry. The effect of ldcBRB is relatively small to both the BRB and the outlet errors
with the smallest value of  PBRB,c, as  the  BRB remains as the rate-limiting part. But as
PBRB,c increases the importance of ldcBRB increases as it partly defines the permeability of
the upper part of the channel. The differences between the BRB and the outlet errors are
small and mainly caused by the constant values of the other three parameters.
Parameter  lBRBpc is more significant than  ldcBRB,  especially  for the outlet  error and
lower permeabilities. When  lBRBpc is short, perfusion flow facilitates the solute move-
ment, also near BRB. As lBRBpc increases, the distance a molecule has to diffuse without
perfusion increases. This does not have a significant effect on the BRB error with lowest
value of  PBRB,c, but the effect  on the  outlet error is noticeable as  the lower part of the
BRB forms an additional permeability component to the system, as discussed earlier.
The small increase in the BRB error as lBRBpc increases is probably due to the fact that
the solutes do not diffuse  very fast away from the BRB without perfusion. This de-
creases the concentration gradient over  the  BRB. As the value of  PBRB,c increases, the
differences between the BRB and outlet errors begins to vanish. This is because of the
decreasing relevance of  the  BRB as a permeability component. With  PBRB,c = 1×10−4
cm s−1, the behavior of both errors is mainly influenced by the diffusion rate, not PBRB,c.
As clearly shown in Figure 4.9 the effect of channel height hpc to both the BRB and
the outlet errors is quite insignificant. There are only small differences between different
values of hpc, apart from hpc = 0.15 mm. As solutes diffuse into the perfusion channel,
the preferred method of transport changes  from diffusion to convection. The channel
height is less important, as convection is a much faster method of transport than diffu-
sion and as the transport does not occur in vertical direction. The different behavior of
hpc = 0.15 mm might be a result of changed flow pattern within the BRB channel. An-
other option is that the FEM mesh within the perfusion channel is too rough, so the
channel is only a few elements high, which may affect the calculated results.
Increasing the flow rate (mfr) in the perfusion channel does decrease the error  to
some extent. This can be explained by the fact that as the value of mfr increases, its in-
fluence  on the BRB channel reaches higher.  This leads to faster transport  of solutes
away from the BRB, which in turn increases the concentration gradient over the BRB.
However, as the changes in both the BRB and outlet errors are quite small, the behavior
might be a result of COMSOL, as there are some variation in the calculations.
As a summary, the BRB permeability coefficient is the parameter with the largest ef-
fect on the measurement errors, which follows from the importance of the free diffusion
coefficient to the measured values. The differences in errors when the other model pa-
rameters are changed follow from the changes in diffusion distances.
Measurability of the acceptor chamber concentration
The solute concentration of the acceptor chamber (cac) was studied by varying mfr and
donor chamber concentration (cdc). As discussed with the error analysis, the effect of mfr
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to the outlet error is not important. However, for the measurability of cac, it has a large
role.  The increasing  value  of  mfr deteriorates  the  measurability  fast,  especially  with
small permeabilities, as there is smaller solute  a flux going through the outlet. As the
donor and acceptor concentrations are directly proportional to each other,  it  is  quite
clear that a large donor concentration leads to a large acceptor concentration.
5.2.2 Model limitations
Using FEM to model the diffusion imposes some limitations for the accuracy of the
model. First of all, the accuracy of the mesh is an important factor. This can especially
be seen with the smallest values of channel height, as in these cases the channel is only
a few elements in height. This means that the changes and gradients in flow rates and
concentrations, which can probably be quite drastic in such small channel, are not mod-
eled correctly. However,  the increasing the element number would lead to very high
computational loads in larger channel heights.
In addition to the mesh, the physics used in the simulations are simplifications of the
real  situations. The physics for the diffusion only represent the diffusing molecules as
concentrations. This means that the model does not take into account any real interac-
tions between the diffusing molecule and the system or BRB. For example, the mole-
cules may bind to the chamber walls and especially to the melanin in  the BRB. How-
ever, the problems with the physics are probably smaller than the mesh, as Fick's second
law captures the  rate  limiting step of the molecular movement: the diffusion. Also, as
Fick's second law is an idealized model of diffusion, the present chamber model at most
overestimates the molecular transport rate in the system. This is because all the interac-
tions would hinder the diffusion rate. So, even if the model is not entirely correct, the
real situation with all the interactions not modeled here is probably worse.
5.2.3 Summary
As the importance of different dimensional and measurement-based parameters  to the
functionality of the chamber was studied, it was quite surprising that the most important
parameter concerning the functionality of the chamber is not any of these, but actually
the free diffusion coefficient. Basically, the slow movement of molecules over large dis-
tances creates the error in the system. The four different parameters create some error,
which mainly follows from the fact that they define the diffusion distances. The greatest
effect on error was seen when the permeability coefficient of the BRB was varied. This
change can be traced back to the free diffusion coefficient. It is quite clear, that with
larger permeability coefficients, the measured permeability is not as much based on the
BRB permeability as it is to the permeability – or error – of the chamber. The measura-
bility of the concentration in the acceptor chamber is important for the usage of this
kind of a system, and the concentration is highly dependent on the flow rate and donor
concentration.
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Based on a literature review, there are no published models of the chamber function-
ality. Thus this model may be the first to show the challenges in the ability of diffusion
chambers  to measure the membrane permeability.  The problems  this  model revealed
presumably affect  most of the diffusion chambers, and especially those that depend at
least partly on passive diffusion. Generally, the ability of these chambers to measure the
actual absolute values of permeability and the results obtained with them should be con-
sidered with caution.
5.3 The models together
Physiological  models,  and especially mathematical  models,  have  a  great  importance
when studying the properties of the BRB in health and disease. Although the two mod-
els are  very different in nature, they aim to  create a  comprehensive  understanding of
both the barrier function of  the BRB as well as the methods and tools for studying it.
Both models can together be used to guide the experimental research by combining our
knowledge about the diffusion in the BRB and in the measurement tools. There are no
published models that include both the subject of the measurement and the measurement
tool. In the end, the main objective of these models in a larger context is to mediate the
research on AMD and other similar diseases and facilitate the development of new treat-
ment options.
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6 CONCLUSION
Modeling is a significant part of the research of physiological systems. Models comple-
ment and direct the experimental studies towards the important objectives.  To develop
new treatments for AMD – such as drug therapies or RPE transplantation – the proper-
ties of the BRB in the normal eye and in thes diseased eye has to be studied. Modeling
gives simple methods for this.  Also, to be able to study the  barrier properties of  the
BRB, there has to be suitable tools, such as the diffusion chambers. When utilizing these
tools, the user must understand how the measurement setup behaves and what are the
possible sources of error.
To meet these needs, two mathematical models were constructed in this thesis. The
first model is a passive diffusion model of the BRB based on the physicochemical prop-
erties of the diffusing molecule and the barrier itself. The author combined physical the-
ories of hindered diffusion and dimensional parameters of the BRB from the literature.
The model was constructed, validated and its properties were studied in multiple ways.
The second model was of a conceptual half-perfusion chamber meant for the BRB per-
meability studies, and it was used to study how system dimensions and parameters af-
fect the results measured with the system. This model was a FEM model and the author
constructed it by using the existing physics models in COMSOL Multiphysics software.
The results show that the BRB model does predict the correct magnitude of the BRB
permeabilities, but fails to show the more specific behavior based on the properties of
the diffusing molecules. The TJ model in the present BRB model is novel and more ac-
curate than in the previously published models. Furthermore, this also the first model of
BRB to include the melanin binding. The BRB model also shows that RPE forms the
major barrier against diffusion, as predicted in the literature.  However, BrM limits the
diffusion of highly lipophilic molecules. The effect of choroid to the measured perme-
ability values should also be considered as a noteworthy permeability component due to
its thickness. The largest problem with the model is the transcellular pathway of  the
RPE, which is the most difficult part to model due to the complex interactions between
the solute and the structures of the RPE. Nevertheless, the model does form a good plat-
form for future refinements.
The chamber model shows that the functionality of the half-perfusion chamber ad-
dressed in this thesis is limited by the diffusion rate. As for the dimensions and other pa-
rameters, the system will function at its best when the free diffusion distances are mini-
mized.  Generally, the ability of the diffusion chambers to measure the actual absolute
values of permeability and the results should be considered with caution.
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APPENDIX 1: MOLECULES OF THE BRB MODEL, THEIR 
PROPERTIES AND MEASURED PERMEABILITIES
Table A1.1. The parameter values in the validation of the BRB model.(Ms: molecular
mass;  V:  van  der  Waals  volume;  rs:  radius;  D0:  free  diffusion  coefficient;  log  KP:
partition  coefficient;  log  KD:  distribution  coefficient;  Ka:  association  constant;  qs:
charge)
Molecule Ms (Da) V (Å3) rs (Å) D0 (10−6 cm2 s−1) log KP log KD Ka (µM−1) qs
Atenolol 266.34 261.34 6.24 7.89 0.70 –1.65 0.141 +1
Betaxolol 307.43 313.49 6.66 7.39 2.53 0.31 0.243 +1
Carboxyfluorescein 376.32 299.15 7.30 6.74 3.54 0.16 0.235 −1
Cimetidine 252.34 226.82 6.09 8.08 –0.29 –0.34 0.209 0
Clonidine 230.10 177.15 5.84 8.43 2.49 1.66 0.313 +1
Fluorescein 332.07 271.40 6.90 7.14 3.88 3.86 0.428 0
Gabapentin 171.24 176.16 5.11 9.63 –1.27 –1.27 0.161 0
Levofloxacin 361.37 309.99 7.17 6.87 0.65 –0.28 0.212 −1
Mannitol 182.17 165.06 5.25 9.37 –3.73 –3.73 0.033 0
Memantine 179.30 194.54 5.22 9.44 2.07 –0.78 0.186 +1
Methylene blue 284.40 262.13 6.43 7.66 2.61 2.61 0.363 +1
Methylprednisolone 374.47 356.94 7.28 6.76 1.56 1.56 0.308 0
Metoprolol 257.36 274.24 6.14 8.01 1.75 –0.47 0.202 +1
Nadolol 309.40 305.19 6.68 7.37 0.85 –1.44 0.152 +1
Nicotine 162.12 164.23 4.98 9.88 1.16 –0.31 0.211 +1
Phenylalanine 165.19 155.62 5.03 9.79 –1.18 –1.19 0.165 0
Pindolol 248.32 269.33 6.05 8.14 1.69 –0.53 0.199 +1
Probenecid 285.36 260.88 6.44 7.64 2.44 –0.92 0.179 −1
Propranolol 259.34 257.56 6.17 7.98 2.58 0.36 0.246 +1
Rhodamine 123 345.37 301.75 7.02 7.01 4.01 4.01 0.435 +1
Rhodamine 6G 443.47 420.09 7.89 6.26 5.35 5.33 0.504 0
Sotalol 272.36 252.38 6.30 7.81 –0.40 –2.12 0.117 +1
Timolol 316.42 292.07 6.75 7.29 1.33 –0.97 0.176 +1
Verapamil 454.60 458.65 7.95 6.19 5.04 2.79 0.372 +1
87
Table A1.2. The measured permeability coefficients used in the validation of the BRB
model.
Molecule Measured mean P(10−6 cm s−1) Tissue Reference
Atenolol 2.00 Bovine choroid and BRB Pitkänen et al. 2005
0.01 Bovine choroid and BRB Steuer et al. 2004
1.47 Bovine choroid and BRB Kadam et al. 2011
2.71 Porcine choroid and BRB Kadam et al. 2011
5.67 Human choroid and BRB Kadam et al. 2011
8.09 Bovine choroid and BrM Cheruvu & Kompella 2006
Betaxolol 10.3 Bovine choroid and BRB Pitkänen et al. 2005
0.19 Bovine choroid and BRB Kadam et al. 2011
0.3 Porcine choroid and BRB Kadam et al. 2011
3.49 Human choroid and BRB Kadam et al. 2011
Carboxyfluorescein 0.96 Bovine choroid and BRB Pitkänen et al. 2005
Cimetidine 0.293 Bovine choroid and BRB Steuer et al. 2004
Clonidine 5.04 Bovine choroid and BRB Steuer et al. 2004
Fluorescein 0.18 Bovine choroid and BRB Steuer et al. 2004
1.94 Human BRB (in vivo) Sander et al. 2001
0.92 Bovine choroid and BRB Cheruvu & Kompella 2006
Gabapentin 0.959 Bovine choroid and BRB Steuer et al. 2004
Levofloxacin 59.7 Porcine choroid and BrM Pescina et al. 2012
Mannitol 3.33 Human RPE Rajasekaran et al. 2003
21.34 Bovine choroid and BrM Cheruvu & Kompella 2006
Memantine 31.7 Bovine choroid and BRB Steuer et al. 2004
Methylene blue 21.0 Porcine choroid and BrM Pescina et al. 2012
Methylprednisolone 50.2 Porcine choroid and BrM Pescina et al. 2012
Metoprolol 10.6 Bovine choroid and BRB Pitkänen et al. 2005
0.4 Bovine choroid and BRB Kadam et al. 2011
0.65 Porcine choroid and BRB Kadam et al. 2011
4.53 Human choroid and BRB Kadam et al. 2011
Nadolol 2.03 Bovine choroid and BRB Pitkänen et al. 2005
1.18 Bovine choroid and BRB Kadam et al. 2011
4.62 Porcine choroid and BRB Kadam et al. 2011
2.25 Human choroid and BRB Kadam et al. 2011
Nicotine 16.5 Bovine choroid and BRB Steuer et al. 2004
Phenylalanine 55.02 Human choroid and BrM Hussain et al. 2002
Pindolol 3.48 Bovine choroid and BRB Pitkänen et al. 2005
0.13 Bovine choroid and BRB Kadam et al. 2011
0.11 Porcine choroid and BRB Kadam et al. 2011
3.32 Human choroid and BRB Kadam et al. 2011
Probenecid 0.952 Bovine choroid and BRB Steuer et al. 2004
Propranolol 0.01 Bovine choroid and BRB Kadam et al. 2011
0.096 Porcine choroid and BRB Kadam et al. 2011
1.34 Human choroid and BRB Kadam et al. 2011
77.0 Porcine choroid and BrM Pescina et al. 2012
Rhodamine 123 0.23 Bovine choroid and BRB Steuer et al. 2004
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Molecule Measured mean P(10−6 cm s−1) Tissue Reference
Rhodamine 6G 0.07 Bovine choroid and BrM Cheruvu & Kompella 2006
Sotalol 1.31 Bovine choroid and BRB Kadam et al. 2011
2.24 Porcine choroid and BRB Kadam et al. 2011
6.03 Human choroid and BRB Kadam et al. 2011
Timolol 8.41 Bovine choroid and BRB Pitkänen et al. 2005
0.37 Bovine choroid and BRB Kadam et al. 2011
0.37 Porcine choroid and BRB Kadam et al. 2011
3.99 Human choroid and BRB Kadam et al. 2011
Verapamil 11.6 Bovine choroid and BRB Steuer et al. 2004
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APPENDIX 2: RESULTS OF THE BRB MODEL VALIDATION
Table A2.1. The calculated RPE  (PRPE), BrM  (PBrM),  CE  (PCE) and total  BRB  (PBRB)
permeability values in the validation of the BRB model.  PRPE and PBRB are shown with
and without melanin. All the results have units of cm s−1.
Molecule
PRPE with
melanin
PRPE without
melanin PBrM PCE
PBRB with
melanin
PBRB without
melanin
Atenolol 2.44 2.44 87.1 5340 2.37 2.37
Betaxolol 1.84 1.84 63.0 4780 1.79 1.79
Carboxyfluorescein 1.40 1.40 25.3 4030 1.32 1.32
Cimetidine 2.66 2.66 79.0 5600 2.57 2.57
Clonidine 3.05 38.33 119 6020 2.97 28.85
Fluorescein 1.52 35.28 42.6 4480 1.47 19.21
Gabapentin 4.35 4.35 167 7520 4.24 4.24
Levofloxacin 1.43 1.43 28.0 4170 1.36 1.36
Mannitol 4.06 4.06 150 7180 3.95 3.95
Memantine 4.13 4.14 193 7270 4.05 4.05
Methylene blue 2.17 3.65 75.3 5090 2.11 3.48
Methylprednisolone 1.40 1.40 31.6 4050 1.34 1.34
Metoprolol 2.58 2.58 93.9 5510 2.51 2.51
Nadolol 1.81 1.81 62.1 4750 1.76 1.76
Nicotine 4.62 4.83 232 7820 4.52 4.73
Phenylalanine 4.52 4.54 178 7720 4.41 4.43
Pindolol 2.73 2.73 101 5670 2.65 2.65
Probenecid 2.15 2.15 48.5 5080 2.06 2.06
Propranolol 2.55 2.55 92.4 5480 2.48 2.48
Rhodamine 123 1.48 7.67 47.6 4340 1.43 6.59
Rhodamine 6G 1.26 1.33 20.2 3490 1.19 1.25
Sotalol 2.34 2.34 83.0 5270 2.28 2.28
Timolol 1.72 1.72 58.8 4670 1.67 1.67
Verapamil 1.24 1.24 22.9 3420 1.18 1.18
